<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="pmc-domain-id">1526</journal-id><journal-id journal-id-type="pmc-domain">frontmicrobio</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9306315</article-id><article-id pub-id-type="pmcid-ver">PMC9306315.1</article-id><article-id pub-id-type="pmcaid">9306315</article-id><article-id pub-id-type="pmcaiid">9306315</article-id><article-id pub-id-type="pmid">35875565</article-id><article-id pub-id-type="doi">10.3389/fmicb.2022.908495</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title><italic toggle="yes">Brucella melitensis</italic> Wzm/Wzt System: Changes in the Bacterial Envelope Lead to Improved Rev1&#916;<italic toggle="yes">wzm</italic> Vaccine Properties</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mena-Bueno</surname><given-names initials="S">Sara</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1747390/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Poveda-Urkixo</surname><given-names initials="I">Irati</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1747312/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Irazoki</surname><given-names initials="O">Oihane</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/367411/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Palacios</surname><given-names initials="L">Leyre</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cava</surname><given-names initials="F">Felipe</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/108025/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zabalza-Barangu&#225;</surname><given-names initials="A">Ana</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1859316/overview"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Grill&#243;</surname><given-names initials="MJ">Mar&#237;a Jes&#250;s</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/734548/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Animal Health Department, Instituto de Agrobiotecnolog&#237;a (IdAB, CSIC-Gobierno de Navarra)</institution>, <addr-line>Pamplona</addr-line>, <country>Spain</country></aff><aff id="aff2"><sup>2</sup><institution>Agronomy, Biotecnology and Food Department, Universidad P&#250;blica de Navarra (UPNA)</institution>, <addr-line>Pamplona</addr-line>, <country>Spain</country></aff><aff id="aff3"><sup>3</sup><institution>Laboratory for Molecular Infection Medicine Sweden, Department of Molecular Biology, Ume&#229; Centre for Microbial Research, Ume&#229; University</institution>, <addr-line>Ume&#229;</addr-line>, <country>Sweden</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Roy Martin Roop II, East Carolina University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Jerod Skyberg, University of Missouri, United States; David O&#8217;Callaghan, Universit&#233; de Montpellier, France</p></fn><corresp id="c001">*Correspondence: Mar&#237;a Jes&#250;s Grill&#243;, <email>mj.grillo@csic.es</email></corresp><fn fn-type="other" id="fn004"><p>This article was submitted to Infectious Agents and Disease, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>7</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>13</volume><issue-id pub-id-type="pmc-issue-id">400063</issue-id><elocation-id>908495</elocation-id><history><date date-type="received"><day>30</day><month>3</month><year>2022</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>04</day><month>07</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>23</day><month>07</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-14 20:25:24.417"><day>14</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2022 Mena-Bueno, Poveda-Urkixo, Irazoki, Palacios, Cava, Zabalza-Barangu&#225; and Grill&#243;.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Mena-Bueno, Poveda-Urkixo, Irazoki, Palacios, Cava, Zabalza-Barangu&#225; and Grill&#243;</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fmicb-13-908495.pdf"/><abstract><p>The lipopolysaccharide (LPS) O-polysaccharide (O-PS) is the main virulence factor in <italic toggle="yes">Brucella</italic>. After synthesis in the cytoplasmic membrane, O-PS is exported to the periplasm by the Wzm/Wzt system, where it is assembled into a LPS. This translocation also engages a bactoprenol carrier required for further biosynthesis pathways, such as cell wall biogenesis. Targeting O-PS export by blockage holds great potential for vaccine development, but little is known about the biological implications of each Wzm/Wzt moiety. To improve this knowledge and to elucidate its potential application as a vaccine, we constructed and studied <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> single- and double-deletion mutants, using the attenuated strain <italic toggle="yes">Brucella melitensis</italic> Rev1 as the parental strain. This allowed us to describe the composition of <italic toggle="yes">Brucella</italic> peptidoglycan for the first time. We observed that these mutants lack external O-PS yet trigger changes in genetic transcription and in phenotypic properties associated with the outer membrane and cell wall. The three mutants are highly attenuated; unexpectedly, Rev1&#916;<italic toggle="yes">wzm</italic> also excels as an immunogenic and effective vaccine against <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">Brucella ovis</italic> in mice, revealing that low persistence is not at odds with efficacy. Rev1&#916;<italic toggle="yes">wzm</italic> is attenuated in BeWo trophoblasts, does not infect mouse placentas, and is safe in pregnant ewes. Overall, these attributes and the minimal serological interference induced in sheep make Rev1&#916;<italic toggle="yes">wzm</italic> a highly promising vaccine candidate.</p></abstract><kwd-group><kwd>lipopolysaccharide</kwd><kwd>Wzm/Wzt system</kwd><kwd>Rev1&#916;<italic toggle="yes">wzm</italic> vaccine</kwd><kwd><italic toggle="yes">Brucella</italic> envelope</kwd><kwd>pregnant sheep</kwd><kwd>pregnant mice</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>Agencia Estatal de Investigaci&#243;n</institution><institution-id institution-id-type="doi">10.13039/501100011033</institution-id></institution-wrap></funding-source><award-id award-type="contract" rid="cn001">AGL2014-58795-C4-2-R</award-id><award-id award-type="contract" rid="cn001">RTI2018-098658-B-C21</award-id></award-group><award-group><funding-source id="cn002"><institution-wrap><institution>Direcci&#243;n General de Industria, Energia y Proyectos Estrategicos S3, Gobierno de Navarra</institution><institution-id institution-id-type="doi">10.13039/501100020082</institution-id></institution-wrap></funding-source><award-id award-type="contract" rid="cn002">PT068-2018</award-id><award-id award-type="contract" rid="cn002">PT007-2019</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="0"/><equation-count count="0"/><ref-count count="128"/><page-count count="20"/><word-count count="14203"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>Brucellosis is one of the most relevant zoonosis worldwide and is caused by bacteria of the genus <italic toggle="yes">Brucella</italic>. These pathogens infect a wide range of domestic and wild animals. <italic toggle="yes">Brucella melitensis</italic> infects predominantly small ruminants and is also the most frequent <italic toggle="yes">Brucella</italic> species in humans in endemic regions. To date, there are no safe vaccines for humans, and antibiotic treatments are onerous with frequent relapses so that the most rational strategy is to control and eradicate animal infections (<xref rid="B14" ref-type="bibr">Blasco, 1997</xref>). In small ruminants, Rev1 is the only vaccine recommended (<xref rid="B81" ref-type="bibr">OIE, 2018</xref>). However, although attenuated, Rev1 can be pathogenic for animals (for instance, it induces abortions in pregnant ewes; <xref rid="B14" ref-type="bibr">Blasco, 1997</xref>) and can infect humans (<xref rid="B112" ref-type="bibr">Spink et al., 1962</xref>; <xref rid="B15" ref-type="bibr">Blasco and D&#237;az, 1993</xref>). Thus, finding a safer alternative vaccine is a priority worldwide.<sup><xref rid="footnote1" ref-type="fn">1</xref></sup> To this end, much research effort has focused on lipopolysaccharide (LPS) modifications and, more specifically, on removing the <italic toggle="yes">N</italic>-formyl-perosamine homopolymer O-polysaccharide (O-PS) (<xref rid="B128" ref-type="bibr">Zhao et al., 2018</xref>). Besides being a main virulence factor, O-PS is the immunodominant antigen in <italic toggle="yes">Brucella</italic> (<xref rid="B111" ref-type="bibr">Spink and Anderson, 1954</xref>), which is necessary to elicit a protective adaptive immune-response (<xref rid="B75" ref-type="bibr">Montaraz et al., 1986</xref>; <xref rid="B45" ref-type="bibr">Grill&#243; et al., 2006b</xref>).</p><p>Pathways involved in O-PS biosynthesis have been explored as potential targets for vaccine developments (<xref rid="B123" ref-type="bibr">Whitfield, 1995</xref>; <xref rid="B103" ref-type="bibr">Schurig et al., 2002</xref>; <xref rid="B78" ref-type="bibr">Moriy&#243;n et al., 2004</xref>; <xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>). In <italic toggle="yes">Brucella</italic>, this molecule is formed in the inner side of the cytoplasmic membrane. It is then translocated to the periplasm by an ATP-binding cassette (ABC) transport system that comprises two essential proteins, Wzt and Wzm, whereby the hydrophilic ATP-binding Wzt is coupled by a unique interface (<xref rid="B13" ref-type="bibr">Bi et al., 2018</xref>) to the transmembrane ring-shaped Wzm (<xref rid="B26" ref-type="bibr">Cuthbertson et al., 2007</xref>; <xref rid="B73" ref-type="bibr">Mohammad et al., 2016</xref>; <xref rid="B18" ref-type="bibr">Caffalette and Zimmer, 2021</xref>). This system is broadly conserved among gram-negative bacteria (<xref rid="B123" ref-type="bibr">Whitfield, 1995</xref>; <xref rid="B68" ref-type="bibr">Lerouge et al., 2001</xref>; <xref rid="B53" ref-type="bibr">Hug and Feldman, 2011</xref>; <xref rid="B19" ref-type="bibr">Caffalette et al., 2020</xref>), whereby Wzm is strongly conserved, while Wzt has a C-terminal domain (C-Wzt), with a unique structural element that determines the specificity of the O-PS transporter (<xref rid="B55" ref-type="bibr">Izquierdo et al., 2003</xref>; <xref rid="B27" ref-type="bibr">Cuthbertson et al., 2005</xref>, <xref rid="B26" ref-type="bibr">2007</xref>). Truncation of <italic toggle="yes">wzm/wzt</italic> genes leads to rough (R) mutants carrying O-PS molecules unlinked to the R-LPS rather than smooth (S)-LPS; however, little is known about the effect of each component on <italic toggle="yes">Brucella</italic>. O-PS export further involves the undecaprenol pyro-phosphate (also known as bactoprenol), which is a universal lipid carrier to which sugar precursors attach to initiate O-PS synthesis and export the whole complex to the periplasm (<xref rid="B117" ref-type="bibr">Valvano, 2003</xref>). Once O-PS is linked to the LPS, the bactoprenol needs to be released back to the inner membrane, where it can participate other polymerization pathways, such as peptidoglycan (PG) recycling (<xref rid="B118" ref-type="bibr">Valvano, 2015</xref>; <xref rid="B119" ref-type="bibr">Vassen, 2018</xref>). Thus, we hypothesized that <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> truncation and blockage of the O-PS export could alter other bacterial structures and/or functions.</p><p>Most <italic toggle="yes">B. melitensis</italic> R mutants were developed from the 16M or H38 virulent strain (<xref rid="B40" ref-type="bibr">Godfroid et al., 2000</xref>; <xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>; <xref rid="B122" ref-type="bibr">Wang Z. et al., 2014</xref>). However, the background of the parental strain can be crucial for the biological properties of the R derivatives (<xref rid="B11" ref-type="bibr">Barrio et al., 2009</xref>). In this work, we built the <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> single- and double-mutants from a <italic toggle="yes">B. melitensis</italic> Rev1 attenuated strain, with the objective of understanding how to increase the structural and functional impact derived from disrupting the O-PS export. For this, we analyzed transcriptional changes and features associated with envelope remodeling of Rev1 Wzm/Wzt mutants vs. 16M&#916;<italic toggle="yes">wzm</italic> (<xref rid="B127" ref-type="bibr">Zabalza Barangu&#225;, 2017</xref>), using state-of-the-art techniques, including transmission electron microscopy (TEM) and ultra-performance liquid chromatography-mass spectrometry (UPLC-MS), as well as <italic toggle="yes">in vivo</italic> experiments in laboratory animals (mice) and in the natural host most susceptible to <italic toggle="yes">B. melitensis</italic> infection (pregnant ewes).</p></sec><sec sec-type="results|discussion" id="S2"><title>Results and Discussion</title><sec id="S2.SS1"><title>Deletion of <italic toggle="yes">wzm</italic> and/or <italic toggle="yes">wzt</italic> Induces <italic toggle="yes">wbkB</italic> and <italic toggle="yes">wbkC</italic> Transcriptional Upregulation, but Only Rev1&#916;<italic toggle="yes">wzm</italic> Induces a Marked <italic toggle="yes">wzt</italic> Upregulation</title><p>After assessing the expected genotypes by sequencing for the Rev1&#916;<italic toggle="yes">wzm</italic>, Rev1&#916;<italic toggle="yes">wzt</italic>, and Rev1&#916;<italic toggle="yes">wzm</italic>&#916;<italic toggle="yes">wzt</italic> mutants (<xref rid="F1" ref-type="fig">Figure 1A</xref>; <xref rid="FS1" ref-type="supplementary-material">Supplementary Figures 1</xref>, <xref rid="FS2" ref-type="supplementary-material">2</xref>, <xref rid="TS3" ref-type="supplementary-material">Supplementary Table 3</xref>), we studied variations by qRT-PCR (<xref rid="TS4" ref-type="supplementary-material">Supplementary Table 4</xref>) for the relative expression of the genes <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic>, <italic toggle="yes">wbk</italic>, and <italic toggle="yes">wbo</italic> O-PS biosynthesis clusters (<xref rid="B40" ref-type="bibr">Godfroid et al., 2000</xref>; <xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>), as well as for <italic toggle="yes">cgs</italic> and <italic toggle="yes">cgt</italic>, which code for the synthesis and export to the periplasm of cyclic glucans. Of note, these sugars, together with the LPS, are envelope components involved in <italic toggle="yes">Brucella</italic> virulence (<xref rid="B50" ref-type="bibr">Haag et al., 2010</xref>; <xref rid="B48" ref-type="bibr">Guidolin et al., 2015</xref>). No transcription of <italic toggle="yes">wzm</italic> and/or<italic toggle="yes">wzt</italic> was detectable in the corresponding single- or double-deletion mutants (<xref rid="F1" ref-type="fig">Figure 1B</xref>). As both genes are sequentially located in the chromosome (<xref rid="B40" ref-type="bibr">Godfroid et al., 2000</xref>), it is generally assumed that <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutations should cause an analogous effect and that the deletion of <italic toggle="yes">wzm</italic> would hinder <italic toggle="yes">wzt</italic> expression. Strikingly, however, Rev1&#916;<italic toggle="yes">wzm</italic> showed significant (<italic toggle="yes">p</italic> &lt; 0.001) overexpression of <italic toggle="yes">wzt</italic>, but Rev1&#916;<italic toggle="yes">wzt</italic> showed unchanged expression of <italic toggle="yes">wzm</italic> (e.g., similar to the parental). In agreement with this, the <italic toggle="yes">in silico</italic> study revealed that the start codon of <italic toggle="yes">wzt</italic> overlaps the stop codon by one nucleotide. This overlap suggests the existence of a multiple reading frame, a feature conserved across microbial genomes and a common regulation mechanism (<xref rid="B59" ref-type="bibr">Johnson and Chisholm, 2004</xref>). Additionally, it has been proposed that these two genes could constitute a sole operon for other gram-negative bacteria (<xref rid="B91" ref-type="bibr">Rocchetta and Lam, 1997</xref>; <xref rid="B41" ref-type="bibr">Goldberg, 1999</xref>). Thus, it seems reasonable that a deletion upstream of <italic toggle="yes">wzm</italic> not only maintains but also alters the expression of <italic toggle="yes">wzt</italic>. In sum, we demonstrate that <italic toggle="yes">wzm</italic> deletion allows the transcription of <italic toggle="yes">wzt</italic> and causes its overexpression in Rev1&#916;<italic toggle="yes">wzm</italic>.</p><fig position="float" id="F1" orientation="portrait"><label>FIGURE 1</label><caption><p>Deletion of <italic toggle="yes">wzm</italic> and/or <italic toggle="yes">wzt</italic> leads to different transcriptional regulations of O-PS biosynthesis genes. <bold>(A)</bold> Schematic representation of the forward (F) and reverse (R) primers designed onto <italic toggle="yes">wzm</italic> (pink) and <italic toggle="yes">wzt</italic> (green) to delete their inner regions (gray), with the respective start/stop codons in the wild-type (WT) parental strain and resulting mutants. <bold>(B)</bold> Heat maps representing the mean values of the genetic relative expression (fold-change; mean &#177; SD) determined by qRT-PCR in Rev1&#916;<italic toggle="yes">wzm</italic>, Rev1&#916;<italic toggle="yes">wzt</italic>, Rev1&#916;<italic toggle="yes">wzm</italic>&#916;<italic toggle="yes">wzt</italic> vs. Rev1 control (upper panel; <italic toggle="yes">n</italic> = 5), including 16M&#916;<italic toggle="yes">wzm</italic> and Rev1 vs. 16M control (lower panel; <italic toggle="yes">n</italic> = 2) for comparative purpose. Fisher&#8217;s LSD test: <sup>***</sup><italic toggle="yes">p</italic> &#8804; 0.001, <sup>**</sup><italic toggle="yes">p</italic> &#8804; 0.01, *<italic toggle="yes">p</italic> &#8804; 0.05 vs. Rev1 or 16M control (base line = 1).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g001.jpg"/></fig><p>Additionally, the three Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants showed enhanced expression (<italic toggle="yes">p</italic> &lt; 0.05) of <italic toggle="yes">wbkB</italic> and <italic toggle="yes">wbkC</italic> with respect to Rev1 (note that <italic toggle="yes">wbkB</italic> encodes an enzyme of unconfirmed function, and, <italic toggle="yes">wbkC</italic>, a formyltransferase; <xref rid="B40" ref-type="bibr">Godfroid et al., 2000</xref>). This finding opens the possibility of antigenic changes in the nascent O-PS, although shortening would not be expected, as no signs of repressed expression were detected. Comparatively, 16M<italic toggle="yes">wzm</italic> showed not only overexpression of these three genes (e.g., <italic toggle="yes">wbkB, wbkC, and wzt</italic>) but also upregulation of <italic toggle="yes">gmd</italic> vs. the 16M parental strain, and this was not reproduced in Rev1<italic toggle="yes">wzm</italic>. With respect to the parental strains, Rev1 showed significant upregulation of <italic toggle="yes">gmd</italic> and downregulation of <italic toggle="yes">wbkA</italic>, <italic toggle="yes">wbkD</italic>, <italic toggle="yes">wbkE</italic>, <italic toggle="yes">wbkF</italic>, <italic toggle="yes">cgs</italic>, and <italic toggle="yes">cgt</italic> genes. Of note, <italic toggle="yes">cgs</italic> and <italic toggle="yes">cgt</italic> encode for cyclic glucans, which are involved in evading host immune response (<xref rid="B17" ref-type="bibr">Briones et al., 2001</xref>; <xref rid="B6" ref-type="bibr">Arellano-Reynoso et al., 2005</xref>; <xref rid="B50" ref-type="bibr">Haag et al., 2010</xref>; <xref rid="B94" ref-type="bibr">Roset et al., 2014</xref>), osmotic resistance (<xref rid="B94" ref-type="bibr">Roset et al., 2014</xref>), and oxidative and detergent pressure resistance (<xref rid="B72" ref-type="bibr">Mirabella et al., 2013</xref>). Thus, this result is consistent with the attenuation of Rev1.</p></sec><sec id="S2.SS2"><title>The Cytoplasmic O-Polysaccharide of Rev1 <italic toggle="yes">wzm/wzt</italic> Mutants Shows Antigenic Features</title><p>In standard tests for <italic toggle="yes">Brucella</italic> typing (<xref rid="B1" ref-type="bibr">Alton et al., 1988</xref>), the three mutants showed the expected R-LPS phenotype, the typical small colonial size of Rev1 (<xref rid="B44" ref-type="bibr">Grill&#243; et al., 2000</xref>) and Rev1 inhibition by penicillin G (P<sub>5</sub>) and safranin O (Saf<sub>100</sub>) (<xref rid="TS5" ref-type="supplementary-material">Supplementary Table 5</xref>). The complete core and the presence of O-PS in <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants were evidenced by alkaline silver staining and Western blot with anti-M monospecific serum, respectively, in whole-cell inactivated bacteria (<xref rid="F2" ref-type="fig">Figure 2A</xref>). We confirmed that the O-PS was not exposed at the mutant outer membrane (OM), since it was not detected using purified LPS samples (<xref rid="F2" ref-type="fig">Figure 2B</xref>), as reported for other gram-negative bacteria (<xref rid="B49" ref-type="bibr">Guo et al., 2017</xref>; <xref rid="B76" ref-type="bibr">Moosavian et al., 2020</xref>). Using an anti-M monospecific serum for Western blotting (<xref rid="F2" ref-type="fig">Figure 2A</xref>) revealed a faint, smeared band at 35&#8211;48 kDa in Rev1 mutants that were absent in BmH38R<italic toggle="yes">manB</italic><sub><italic toggle="yes">core</italic></sub> (control) and were very strong (25&#8211;75 kDa) in Rev1 and complemented strains. Further analysis with anti-C/Y 33H8 and 42D2mAbs showed O-PS in <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants but at lower reactivity than in Rev1 and 16M (<xref rid="F2" ref-type="fig">Figure 2C</xref>). As O-PS biosynthesis was not downregulated, differences in reactivity could be due to low amounts of O-PS in the mutants. This hypothesis is compatible with a capture of bactoprenol by the nascent non-translocated O-PS (<xref rid="B91" ref-type="bibr">Rocchetta and Lam, 1997</xref>), making it unavailable for further biosynthesis. Both <italic toggle="yes">B. melitensis</italic> S-LPS strains were less reactive with 33H8 than with 42D2 (which is evident even after extended exposure time), and Rev1 systematically exhibited stronger signals with 33H8 than with 16M (<xref rid="F2" ref-type="fig">Figure 2C</xref>), evidencing different O-PS epitope compositions.</p><fig position="float" id="F2" orientation="portrait"><label>FIGURE 2</label><caption><p>Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants express R-LPS with a complete core and a cytoplasmic O-PS reacting with mAbs. <bold>(A)</bold> Whole-cell phenol-inactivated bacteria or <bold>(B)</bold> purified LPS profiles detected by modified periodate-alkaline silver staining (upper panels) or by WB with anti-M monospecific serum (lower panels). <bold>(C)</bold> O-PS epitopes of whole bacteria recognized by the mAbs 33H8 for 20 min of exposure (the upper panel) or 42D2 for 6 min (the middle panel); anti-<italic toggle="yes">B. ovis</italic> serum was run as loading control on the same 42D2 blot (the lower panel). <bold>(D)</bold> Western blot with anti-Rev1, anti-Rev1&#916;<italic toggle="yes">wzm</italic>, or anti-16M&#916;<italic toggle="yes">wzm</italic> immune sheep sera. The images presented in the same groups were processed in parallel, and the results are representative of reproducible experiments. WM, pre-stained weight Marker VI (PanReac AppliChem, Castellar del Vall&#233;s, Barcelona, Spain).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g002.jpg"/></fig><p>Rev1 mutants reacted strongly with sera from sheep infected with Rev1&#916;<italic toggle="yes">wzm</italic>, showing a &#8776;35&#8211;48 kDa O-PS-smeared band as well as a distinct band at &#8776;29 kDa, which was also detected (faintly) by anti-Rev1 but not by anti-16M&#916;<italic toggle="yes">wzm</italic> sheep sera (<xref rid="F2" ref-type="fig">Figure 2D</xref>). This 29 kDa band was absent in 16M parental and mutant strains but observed in Rev1 by a Western blot with heat-treated anti-Rev1&#916;<italic toggle="yes">wzm</italic> serum (data not shown). This result suggests the presence of an Omp that is unlinked in Rev1 and covalently bound to PG in 16M, as reported for <italic toggle="yes">Brucella abortus</italic> Omp2b and Omp25 (<xref rid="B39" ref-type="bibr">Godessart et al., 2021</xref>).</p></sec><sec id="S2.SS3"><title>Rev1 <italic toggle="yes">wzm/wzt</italic> Mutants Exhibit High Sensitivity to Antibiotics and Cationic Dyes</title><p>The presence of 10% CO<sub>2</sub> inhibited the growth of 16M&#916;<italic toggle="yes">wzm</italic>, as previously reported (<xref rid="B127" ref-type="bibr">Zabalza Barangu&#225;, 2017</xref>), but not the growth of the Rev1 mutants. Also, the Rev1 mutants were more susceptible than Rev1 to streptomycin (Str<sub>2</sub>.<sub>5</sub>), polymyxin B (PxB<sub>1</sub>.<sub>5</sub>), and colistin (Col<sub>4</sub>), with no differences between mutants (<xref rid="TS6" ref-type="supplementary-material">Supplementary Table 6</xref>). Regarding the susceptibility to the antibiotics of choice for treating human brucellosis (<xref rid="B7" ref-type="bibr">Ariza et al., 1986</xref>), the three mutants were more susceptible than Rev1 to streptomycin and rifampicin in MIC and MBC<sub>90</sub>; furthermore, a synergistic effect with doxycycline was detected in a solid medium, particularly for streptomycin (<italic toggle="yes">p</italic> &#8804; 0.001), leading to almost complete inhibition of mutant growth (<xref rid="TS7" ref-type="supplementary-material">Supplementary Table 7</xref>). These results suggest that, in case of accidental human inoculation, conventional treatment would be successful, in contrast to that reported for Rev1 (<xref rid="B15" ref-type="bibr">Blasco and D&#237;az, 1993</xref>; <xref rid="B46" ref-type="bibr">Grill&#243; et al., 2006a</xref>).</p><p>The inhibition observed with Saf<sub>100</sub>, a basic monovalent cationic dye largely adsorbed by hydrophobic surfaces (<xref rid="B8" ref-type="bibr">Atun et al., 1998</xref>) as described for crystal violet-oxalate (<xref rid="B87" ref-type="bibr">Popescu and Doyle, 1996</xref>), could represent changes in the OM and cell walls (<xref rid="B57" ref-type="bibr">Jankowski et al., 2005</xref>). Thus, we quantified the susceptibility of the mutants to a lower concentration of this dye (Saf<sub>50</sub>), which gave only a 6% viability of mutants, in contrast to (<italic toggle="yes">p</italic> &#8804; 0.001) the 87.8% of Rev1 parental strains (<xref rid="F3" ref-type="fig">Figure 3A</xref>). Rev1 survival could be explained by the hydrophilic hindrance of the S-LPS (<xref rid="B80" ref-type="bibr">Nikaido and Vaara, 1985</xref>; <xref rid="B40" ref-type="bibr">Godfroid et al., 2000</xref>) and/or by buffering of the free radicals generated by this dye by CO<sub>2</sub> (<xref rid="B57" ref-type="bibr">Jankowski et al., 2005</xref>). However, since BmH38R<italic toggle="yes">manB</italic><sub><italic toggle="yes">core</italic></sub> survived (72.5%) more than <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants, safranin O susceptibility suggests that the OM undergoes a particular reorganization, resulting in more exposed lipid A and core moieties in the mutants (<xref rid="B116" ref-type="bibr">Vaara, 1992</xref>; <xref rid="B83" ref-type="bibr">Perevoshchikova et al., 2009</xref>; <xref rid="B24" ref-type="bibr">Clifton et al., 2016</xref>; <xref rid="B36" ref-type="bibr">Fontana et al., 2016</xref>).</p><fig position="float" id="F3" orientation="portrait"><label>FIGURE 3</label><caption><p>Outer membrane properties of <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants are modified in comparison with Rev1. <bold>(A)</bold> Inhibition by the cationic dye safranin O at 50 &#956;g/ml (Saf<sub>50</sub>) in BAB-S and 10% CO<sub>2</sub> represented as surviving bacteria (%; mean &#177; SD; <italic toggle="yes">n</italic> = 3) vs. the standard growth condition. <bold>(B)</bold> Autoagglutination in static culture determined by spectrophotometry (mean &#177; SD; <italic toggle="yes">n</italic> = 2; representative result). <bold>(C)</bold> Surface charge measured by Zeta-potential (mean &#177; SD) in absence (<italic toggle="yes">n</italic> = 4) or presence (<italic toggle="yes">n</italic> = 2) of poly-L-lysine. <bold>(D)</bold> Hydrophobicity based on differential partitioning in aqueous-hydrocarbon solution (mean &#177; SD; <italic toggle="yes">n</italic> = 3). <bold>(E)</bold> Biofilm formation quantified by crystal violet staining (mean &#177; SD; <italic toggle="yes">n</italic> = 3). <bold>(F)</bold> EPS analysis by the intensity of Congo Red (upper row; red line) or Calcofluor (the low row; the discontinuous blue line). <bold>(G)</bold> Representative TEM images with negative stain in which EPS and OMVs are indicated by white and black arrows, respectively; scale bars = 200 nm. Fisher&#8217;s LSD test; <sup>***</sup><italic toggle="yes">p</italic> &#8804; 0.001, *<italic toggle="yes">p</italic> &#8804; 0.05 vs. the other groups.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g003.jpg"/></fig></sec><sec id="S2.SS4"><title>Blocking O-Polysaccharide Transport Causes Pleiotropic Changes Associated With the Outer Membrane and Cell Wall</title><p>Lipopolysaccharide biosynthesis is generally related to other cellular components involved in bacterial integrity (<xref rid="B77" ref-type="bibr">Mor&#232; et al., 2019</xref>). For instance, R-LPS and O-PS deficiencies have been associated with interrelated properties, such as spontaneous autoagglutination (<xref rid="B20" ref-type="bibr">Caro-Hern&#225;ndez et al., 2007</xref>), adhesion to solid layers (<xref rid="B79" ref-type="bibr">Nakao et al., 2012</xref>), increased hydrophobicity, and negative surface charge (<xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>). Indeed, surface adhesion is dependent on the bacterial charge and the hydrophobic nature of the substrate, e.g., polystyrene (<xref rid="B35" ref-type="bibr">Fletcher and Loeb, 1979</xref>). Accordingly, these properties were found in the three mutants (<xref rid="F3" ref-type="fig">Figures 3B&#8211;E</xref>).</p><p>Extracellular polymeric substances (EPS) are heterogeneous components typical of biofilm and stain differently by Congo Red or by Calcofluor (<xref rid="B126" ref-type="bibr">Wood, 1980</xref>). We found that both dyes bound moderately to Rev1 and its mutants, but only minimally to 16M and 16M&#916;<italic toggle="yes">wzm</italic> (<xref rid="F3" ref-type="fig">Figure 3F</xref>); these differences seem to be associated with the nature of the parental strain, as revealed by BmH38R<italic toggle="yes">manB</italic><sub><italic toggle="yes">core</italic></sub> and <italic toggle="yes">B. abortus</italic>2308 controls, and have been previously related to host preference and virulence (<xref rid="B115" ref-type="bibr">Uzureau et al., 2007</xref>). Although the acquisition of fine images of the native EPS is a major challenge due to its low contrast and tendency to collapse (<xref rid="B31" ref-type="bibr">Dohnalkova et al., 2011</xref>), we successfully detected the presence of EPS in Rev1 and its mutants by transmission electron microscopy (TEM), which revealed it to be a globular structure surrounding both fibrous and hydrated shapes (<xref rid="F3" ref-type="fig">Figure 3G</xref>).</p><p>Other interesting structures promoting adhesiveness to solid surfaces in <italic toggle="yes">Brucella</italic> are the OM vesicles (OMVs), commonly called blebs (<xref rid="B38" ref-type="bibr">Godefroid et al., 2010</xref>). Blebs are nanovesicles released from the OM whose composition (<xref rid="B37" ref-type="bibr">Gamazo and Moriy&#243;n, 1987</xref>; <xref rid="B9" ref-type="bibr">Avila-Calder&#243;n et al., 2020</xref>; <xref rid="B95" ref-type="bibr">Ruiz-Palma et al., 2021</xref>) and amount (<xref rid="B109" ref-type="bibr">Solanki et al., 2021</xref>) have been associated with the lack of O-PS, and they are overproduced in strains that auto-agglutinate (<xref rid="B38" ref-type="bibr">Godefroid et al., 2010</xref>). As shown by TEM (<xref rid="F3" ref-type="fig">Figure 3G</xref>), the mutants showed abundant OMVs as outward bulges protruding from the surface or as already detached vesicles, while the OM maintained its integrity. In stark contrast, we did not find even a single OMV in Rev1. These structural changes could indicate a rearrangement of cell envelope components.</p><p>The OM and the cell wall are covalently linked (<xref rid="B39" ref-type="bibr">Godessart et al., 2021</xref>), and their consistency is directly responsible for bacterial osmotic protection (<xref rid="B77" ref-type="bibr">Mor&#232; et al., 2019</xref>). In our studies, all strains grew well in sucrose hyperosmotic and hypoosmotic conditions; however, fewer than 50% of <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants, and 10% of BmH38R<italic toggle="yes">manB</italic><sub><italic toggle="yes">core</italic></sub> survived in a hyperosmotic.5-M NaCl medium, while the growth of Rev1 was unaltered (<xref rid="F4" ref-type="fig">Figure 4A</xref>), highlighting the importance of the selected osmolyte to be used (<xref rid="B22" ref-type="bibr">Cheung et al., 2009</xref>; <xref rid="B106" ref-type="bibr">Shabala et al., 2009</xref>; <xref rid="B86" ref-type="bibr">Pilizota and Shaevitz, 2013</xref>; <xref rid="B104" ref-type="bibr">Schuster et al., 2020</xref>). Even though EPS is involved in protecting against osmotic stress and antimicrobials (<xref rid="B31" ref-type="bibr">Dohnalkova et al., 2011</xref>), its presence did not mitigate NaCl stress in Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants.</p><fig position="float" id="F4" orientation="portrait"><label>FIGURE 4</label><caption><p>Rev1<italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants exhibit differences in cell-wall properties. Susceptibility to: <bold>(A)</bold> Hyperosmotic stress, expressed as the percentage of bacteria survival after incubation (37&#176;C, 48 h) of 10<sup>4</sup> CFU/ml in 0.5 M NaCl, plated in BAB; <bold>(B)</bold> Penicillin G expressed as the number of CFU/ml obtained after triplicate culturing (37&#176;C, 8 days) of serial 10-fold dilutions from 10<sup>9</sup> to 10<sup>4</sup> CFU/ml in 0.5 IU/ml of penicillin G vs. BAB plates (P<sub>0</sub>.<sub>5</sub>); and <bold>(C)</bold> Vancomycin, expressed as the percentage of bacteria survival after incubation (37&#176;C, 1 h) of 10<sup>4</sup> CFU/ml in twofold serial dilutions (50&#8211;3.125 mg/ml) of the antibiotic and triplicate plating in BAB; all results represent the mean &#177; SD (<italic toggle="yes">n</italic> = 3) of 2 or 3 independent experiments. <bold>(D)</bold> PG analysis as representative normalized chromatograms of three independent cultures of each strain, showing the relative PG amount and percentage of composition (mean &#177; SD; <italic toggle="yes">n</italic> = 3) of 16M and Rev1 reference and <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutant strains. Non-labeled peaks correspond to unknown muropeptides. Fisher&#8217;s LSD or <italic toggle="yes">t</italic>-tests; <sup>***</sup><italic toggle="yes">p</italic> &#8804; 0.001, <sup>**</sup><italic toggle="yes">p</italic> &#8804; 0.01, *<italic toggle="yes">p</italic> &#8804; 0.05 vs. the other groups or vs. 16M in panel <bold>D</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g004.jpg"/></fig><p>Susceptibility to penicillin G can provide information about cell wall rearrangements, since this &#223;-lactam targets the penicillin-binding proteins (PBPs) involved in PG assembly (<xref rid="B62" ref-type="bibr">Kohanski et al., 2010</xref>), leading to the inhibition of PG transpeptidation and subsequent cell-wall destabilization (<xref rid="B125" ref-type="bibr">Wolter and Lister, 2013</xref>). We observed a total inhibition at P<sub>5</sub> of 10<sup>9</sup> CFU/ml for Rev1 as well as for its derivatives (<xref rid="TS5" ref-type="supplementary-material">Supplementary Table 5</xref>). Thus, we next sought to determine whether using lower concentrations could detect differences between Rev1 and its derivatives. All strains were significantly inhibited in a solid medium at P<sub>0</sub>.<sub>5</sub>, but, surprisingly, the mutants were less inhibited than Rev1 (<xref rid="F4" ref-type="fig">Figure 4B</xref>) and also showed higher MBC<sub>90</sub> (0.84 vs. 42 IU/ml). As target modification is relatively unlikely, the increased resistance of mutants could be due: (i) to PBP being shielded&#8212;by its own substrate (<xref rid="B67" ref-type="bibr">Lepage et al., 1995</xref>) and/or by other cell products or structures (<xref rid="B69" ref-type="bibr">Livermore, 1987</xref>); or (ii) to reduced PBP activity, leading to PG remodeling (<xref rid="B85" ref-type="bibr">Peters et al., 2018</xref>; <xref rid="B77" ref-type="bibr">Mor&#232; et al., 2019</xref>). To further elucidate the PG structure, we studied the susceptibility of the mutants to vancomycin, a non-&#946;-lactam glycopeptide that hinders PG assembly by blocking its precursors (<xref rid="B62" ref-type="bibr">Kohanski et al., 2010</xref>). Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants were more susceptible than the parental Rev1, showing total inhibition at 12.5 mg/ml (<xref rid="F4" ref-type="fig">Figure 4C</xref>); this could indicate changes in the amount and/or composition of the PG that, in absence of the S-LPS building machinery in the periplasm, could facilitate vancomycin activity.</p><p>We therefore analyzed the PG of <italic toggle="yes">B. melitensis</italic> 16M and Rev1 and their derivatives by UPLC-MS (<xref rid="F4" ref-type="fig">Figure 4D</xref>). For PG quantification, Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants presented lower amounts of PG (10&#8211;15% less) than the parental lines; reduction was even more remarkable (30%) for 16M&#916;<italic toggle="yes">wzm</italic> vs. 16 M, in line with previous studies (<xref rid="B64" ref-type="bibr">Kreutzer et al., 1977</xref>). The fact that these mutants showed decreased PG confirms the hypothesis that truncating the Wzm/Wzt system impairs cell wall biogenesis, presumably due to sequestering the complex bactoprenol&#8211;O-PS when the transport is blocked. Furthermore, it would explain the higher susceptibility of the mutants to vancomycin. For the PG structure, we report for the first time the basic PG building block in <italic toggle="yes">B. melitensis</italic>, consisting of GlcNAc-MurNAc-L-Ala-D-Glu-mDAP-D-Ala-D-Ala, which is similar to that of other gram-negative bacteria (<xref rid="B119" ref-type="bibr">Vassen, 2018</xref>). <italic toggle="yes">B. melitensis</italic> PG included the presence of glycine (Gly) rather than Ala at Position 4 of the stem in a relatively small percentage of the muropeptides. For PG composition, we observed significant differences (<italic toggle="yes">p</italic> &#8804; 0.05) between Rev1 and 16M parentals, as well as a general increase of L,D-crosslink and Gly in Rev1, suggesting a more active incorporation of glycine by L,D-transpeptidases (Ldts) than in 16M. Interestingly, 16M&#916;<italic toggle="yes">wzm</italic> had a significant reduction (<italic toggle="yes">p</italic> &#8804; 0.05) of the L,D-crosslink vs. 16M, a trend also observed for Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants vs. Rev1. These compensations underscore the essential, versatile, and functional coupling of LPS, OM, and cell wall biosynthesis, and strongly suggest that a block of O-PS transport causes pleiotropic effects on <italic toggle="yes">Brucella</italic>.</p></sec><sec id="S2.SS5"><title>Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> Mutants Are Highly Attenuated in BALB/c Mice, Highlighting the Immunity Induced by Rev1&#916;<italic toggle="yes">wzm</italic></title><p>Resistance of virulent <italic toggle="yes">Brucella</italic> to soluble factors of the host immune system is essential for their survival <italic toggle="yes">in vivo</italic>. We therefore used <italic toggle="yes">in vitro</italic> models of susceptibility to polymyxins as antimicrobial cationic polypeptides, targeting the LPS phosphate groups (<xref rid="B71" ref-type="bibr">Mart&#237;nez de Tejada et al., 1995</xref>), as well as to normal sheep serum as a source of complement. As previously reported (<xref rid="B113" ref-type="bibr">Stranahan and Arenas-Gamboa, 2021</xref>), R-LPS mutants were highly inhibited by PxB, Col, and serum complements (<xref rid="F5" ref-type="fig">Figures 5A,B</xref>). Moreover, sera from Rev1&#916;<italic toggle="yes">wzm</italic>-immunized sheep showed a marked killing effect on <italic toggle="yes">Brucella ovis</italic> rather than on <italic toggle="yes">B. melitensis</italic> (<xref rid="F5" ref-type="fig">Figure 5C</xref>), a finding that could be explained by the natural absence of O-PS in <italic toggle="yes">B. ovis</italic> that makes their OM proteins more readily accessible to antibodies (<xref rid="B74" ref-type="bibr">Monreal et al., 2003</xref>).</p><fig position="float" id="F5" orientation="portrait"><label>FIGURE 5</label><caption><p>Rev1&#916;<italic toggle="yes">wzm</italic> is highly attenuated and triggers a stronger adaptive immune response than Rev1&#916;<italic toggle="yes">wzt</italic> or Rev1&#916;<italic toggle="yes">wzm</italic>&#916;<italic toggle="yes">wzt</italic> in the BALB/c mice. Susceptibility is shown for: <bold>(A)</bold> Polymyxin B (PxB) or colistin (Col), as models of cationic bactericidal peptides of the innate immune system (mean &#177; SD; <italic toggle="yes">n</italic> = 2); and <bold>(B)</bold> complement-mediated killing by conventional non-immune ovine serum, either complete or heat inactivated (mean &#177; SD; <italic toggle="yes">n</italic> = 2). <bold>(C)</bold> Bacterial killing activity of sera from sheep immunized with Rev1&#916;<italic toggle="yes">wzm</italic> against <italic toggle="yes">B. melitensis</italic> 16M and <italic toggle="yes">B. ovis</italic> PA (BoPA) virulent strains (mean &#177; SD; <italic toggle="yes">n</italic> = 4). <bold>(D)</bold> Kinetics of spleen infections and weights (mean &#177; SD; <italic toggle="yes">n</italic> = 3 at 1 and 4 weeks PI, <italic toggle="yes">n</italic> = 4 at 2 and 3 weeks PI) of the BALB/c mice inoculated IP with 10<sup>8</sup> CFU/mouse of the correspondent mutant; the dashed lines indicate the detection limit (log<sub>10</sub> 5 CFU/spleen = 0.70) and normal splenic weight (0.1 g) in the BALB/c mice. <bold>(E)</bold> Cytokine profiles in blood sera and splenocytes supernatants from the same mice at selected intervals; sera collected at 2, 6, and 24 h PI (<italic toggle="yes">n</italic> = 5) were processed as pools, including two independent experiments for Rev1&#916;<italic toggle="yes">wzm</italic>, Rev1, and PBS groups; dotted lines represent PBS&#8217;s maximum value; blood sera and splenocytes supernatants collected at 1, 2, 3, and 4 weeks PI were processed individually for each necropsied group (mean &#177; SEM). Fisher&#8217;s LSD test; <sup>***</sup><italic toggle="yes">p</italic> &#8804; 0.001, <sup>**</sup><italic toggle="yes">p</italic> &#8804; 0.01, *<italic toggle="yes">p</italic> &#8804; 0.05 immune vs. non-immune sera for a given strain.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g005.jpg"/></fig><p>In the BALB/c mice, the three mutants evidenced extreme attenuation. The vaccinated mice had high levels of spleen colonization at 1 week post-inoculation (PI) but were completely cleared of the mutants by 3&#8211;4 weeks (<xref rid="F5" ref-type="fig">Figure 5D</xref>), in contrast to the longer persistence of Rev1 (<xref rid="FS1" ref-type="supplementary-material">Supplementary Figure 1</xref>). Furthermore, we reproducibly observed a peak of splenomegaly at 2 weeks PI in the mice vaccinated with Rev1&#916;<italic toggle="yes">wzm</italic>, a less pronounced peak in the mice vaccinated with Rev1&#916;<italic toggle="yes">wzm</italic>&#916;<italic toggle="yes">wzt</italic>, and no peak in those vaccinated with Rev1&#916;<italic toggle="yes">wzt</italic> (<xref rid="FS1" ref-type="supplementary-material">Supplementary Figure 1</xref>). This inflammatory response could be associated with an enhanced adaptive immune response mediated by cytokines, which are crucial in protective immunity against <italic toggle="yes">Brucella</italic> (<xref rid="B43" ref-type="bibr">Grill&#243; et al., 2012</xref>; <xref rid="B99" ref-type="bibr">Sancho et al., 2014</xref>). We next analyzed cytokine production in both blood and spleen supernatants at early (&#8804;24 h) and late (&#8804;4 weeks) PI intervals (<xref rid="F5" ref-type="fig">Figure 5E</xref>). Notably, the Rev1&#916;<italic toggle="yes">wzm</italic> mice displayed high serum levels of circulating TNF-&#945; and IFN-&#947; at 24 h PI, and of TNF-&#945; and IL-12 at 2 weeks PI; likewise, the peak of splenomegaly at 2 weeks PI correlated with high levels of proinflammatory TNF-&#945;, IL-6, and IL-12 in these spleens, and a peak of IFN-&#947; at 4 weeks PI, which was delayed with respect to that described for Rev1 (<xref rid="B99" ref-type="bibr">Sancho et al., 2014</xref>). This cytokine relation triggered by Rev1&#916;<italic toggle="yes">wzm</italic> plays a critical role in limiting intracellular replication and quick clearance of the mutant as well as in triggering a protective Th1 immune response (<xref rid="B10" ref-type="bibr">Baldwin and Goenka, 2006</xref>; <xref rid="B33" ref-type="bibr">Dorneles et al., 2015</xref>; <xref rid="B56" ref-type="bibr">Jain-Gupta et al., 2019</xref>). Thus, we demonstrate that Rev1&#916;<italic toggle="yes">wzm</italic> does not require long-lasting persistence to induce protective immunity, in contrast to what is generally accepted for <italic toggle="yes">Brucella</italic>, where Rev1 immunogenicity is dependent on its persistence in mice spleens (<xref rid="B16" ref-type="bibr">Bosseray and Plommet, 1990</xref>; <xref rid="B44" ref-type="bibr">Grill&#243; et al., 2000</xref>; <xref rid="B78" ref-type="bibr">Moriy&#243;n et al., 2004</xref>; <xref rid="B11" ref-type="bibr">Barrio et al., 2009</xref>; <xref rid="B81" ref-type="bibr">OIE, 2018</xref>).</p></sec><sec id="S2.SS6"><title>Rev1&#916;<italic toggle="yes">wzm</italic> Is as Effective as Rev1 Against <italic toggle="yes">Brucella melitensis</italic> and <italic toggle="yes">Brucella ovis</italic> in BALB/c Mice</title><p>On the basis of its immunogenicity, we studied whether the splenomegaly induced by Rev1&#916;<italic toggle="yes">wzm</italic> and the subsequent adaptive immune responses were dose dependent (<xref rid="FS1" ref-type="supplementary-material">Supplementary Figure 1</xref>). Immunization with 10<sup>6</sup> to 10<sup>8</sup> CFU/mouse of Rev1&#916;<italic toggle="yes">wzm</italic> induced equivalent spleen infections, but only 10<sup>8</sup> CFU achieved a homogeneous intragroup infection and splenomegaly, similar to that induced by Rev1 in standard conditions. This confirmed that the immune response to Rev1&#916;<italic toggle="yes">wzm</italic> was dose dependent.</p><p>Efficacy studies on mice use intraperitoneal (IP) or subcutaneous (SC) vaccinations as screening or more exigent models for R-<italic toggle="yes">Brucella</italic> strains, using Rev1 in standard conditions and PBS as efficacy and non-vaccinated controls, respectively (<xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>). Accordingly, we used both routes to evaluate Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants in the BALB/c mice. Against a <italic toggle="yes">B. melitensis</italic> H38 (S-LPS) challenge, Rev1&#916;<italic toggle="yes">wzm</italic> was as protective as Rev1, while Rev1&#916;<italic toggle="yes">wzt</italic> failed by the SC route and Rev1&#916;<italic toggle="yes">wzm</italic>&#916;<italic toggle="yes">wzt</italic> induced heterogeneous responses (<xref rid="F6" ref-type="fig">Figure 6A</xref>). Against a <italic toggle="yes">B. ovis</italic> PA (R-LPS) challenge, Rev1&#916;<italic toggle="yes">wzm</italic> administered <italic toggle="yes">via</italic> SC was also as effective as Rev1, and IP improved the protection conferred by the standard Rev1 vaccine control (<xref rid="F6" ref-type="fig">Figure 6B</xref>).</p><fig position="float" id="F6" orientation="portrait"><label>FIGURE 6</label><caption><p>Rev1&#916;<italic toggle="yes">wzm</italic> protects against virulent <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic> challenges in the BALB/c mice. Efficacy in the BALB/c mice (<italic toggle="yes">n</italic> = 5) IP or SC vaccinated with Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants (10<sup>8</sup> CFU/animal) or with Rev1 reference vaccine (10<sup>5</sup> CFU/animal, SC) or PBS as controls; after 4 weeks, the mice were IP challenged with <bold>(A)</bold> 1 &#215; 10<sup>4</sup> of <italic toggle="yes">B. melitensis</italic> H38:Gm<sup>r</sup> (H38) or <bold>(B)</bold> 5 &#215; 10<sup>5</sup> of <italic toggle="yes">B. ovis</italic> PA:Gm<sup>r</sup> (BoPA:Gm<sup>r</sup>). After 2 or 3 weeks, respectively, the mean &#177; SD (<italic toggle="yes">n</italic> = 5) log<sub>10</sub> CFU of the challenge strain in spleens was determined. Detection limit (log<sub>10</sub> 5 CFU/spleen = 0.70) is indicated with a discontinuous line. Fisher&#8217;s LSD test; <sup>***</sup><italic toggle="yes">p</italic> &#8804; 0.001, <sup>**</sup><italic toggle="yes">p</italic> &#8804; 0.01 vs. Rev1 control.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g006.jpg"/></fig><p>Differences in the immunogenic properties of Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants could be attributable to a differential presence of Wzm or Wzt, supporting the hypothesis that Wzt has a crucial role in conferring immunity (<xref rid="B121" ref-type="bibr">Wang et al., 2014b</xref>). Indeed, we detected <italic toggle="yes">wzt</italic> overexpressed in Rev1&#916;<italic toggle="yes">wzm</italic>. Although the overlap of the start/stop codons could lead to a coupled translation of both proteins, an increase at the translational level could be relevant to O-PS antigenicity. Since Wzt is incorporated into the cytoplasm when Wzm is missing (<xref rid="B107" ref-type="bibr">Singh et al., 2013</xref>; <xref rid="B73" ref-type="bibr">Mohammad et al., 2016</xref>), the accumulation of nascent O-PS molecules in Rev1&#916;<italic toggle="yes">wzm</italic>, presumably attached to the cytoplasmic membrane by the lipid carrier, might have positive feedback on Wzt molecules. Additionally, as Wzt is responsible for O-PS terminal recognition (<xref rid="B117" ref-type="bibr">Valvano, 2003</xref>, <xref rid="B118" ref-type="bibr">2015</xref>; <xref rid="B23" ref-type="bibr">Clarke et al., 2004</xref>; <xref rid="B27" ref-type="bibr">Cuthbertson et al., 2005</xref>, <xref rid="B26" ref-type="bibr">2007</xref>; <xref rid="B51" ref-type="bibr">Hagelueken et al., 2015</xref>; <xref rid="B124" ref-type="bibr">Williams et al., 2017</xref>; <xref rid="B12" ref-type="bibr">Bi and Zimmer, 2020</xref>), its binding to the O-PS could be necessary to provide the antigen with its final conformation and thus with its immunogenic properties.</p></sec><sec id="S2.SS7"><title>Rev1&#916;<italic toggle="yes">wzm</italic> Has a Similar Growth Pattern as Rev1 and Is Stable After <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> Subculturing</title><p>Having selected Rev1&#916;<italic toggle="yes">wzm</italic> as a promising vaccine candidate, we sought possible <italic toggle="yes">in vitro</italic> defects that could affect the bacterial viability and/or scale-up production properties. We determined that Rev1&#916;<italic toggle="yes">wzm</italic> resembled the growth curve of Rev1 yet provided higher turbidity and larger particle size (<xref rid="F7" ref-type="fig">Figures 7A,B</xref>), probably due to the presence of OMVs protruding from the mutant, as evidenced by TEM (<xref rid="F3" ref-type="fig">Figure 3G</xref>). Additionally, Rev1&#916;<italic toggle="yes">wzm</italic> had a similar susceptibility as Rev1 to desiccation, detergents, oxidative stress, and acidic environment (<xref rid="F7" ref-type="fig">Figures 7C&#8211;F</xref>), as well as to lyophilization. These environmental susceptibilities of Rev1 (which have not previously been reported) and its mutant agreed with the detected downregulation of cyclic glucan genes as compared to the virulent strain 16M (<xref rid="F1" ref-type="fig">Figure 1B</xref>). Furthermore, we detected unaltered genotypical [<italic toggle="yes">wzm</italic> deletion and GI-2/<italic toggle="yes">wbk</italic> regions integrity (<xref rid="B70" ref-type="bibr">Mancilla et al., 2013</xref>)] and phenotypical (including inner O-PS production) features after 20 <italic toggle="yes">in vitro</italic> passages as well as after 5 consecutive passages in mice spleens. In contrast, Rev1 viability was significantly reduced after 15 <italic toggle="yes">in vitro</italic> passages, supporting the recommendation of minimizing <italic toggle="yes">in vitro</italic> propagation for quality control (<xref rid="B43" ref-type="bibr">Grill&#243; et al., 2012</xref>). These described results (data not shown) suggested that Rev1&#916;<italic toggle="yes">wzm</italic> is not likely to have antigenic drift.</p><fig position="float" id="F7" orientation="portrait"><label>FIGURE 7</label><caption><p>Rev1&#916;<italic toggle="yes">wzm</italic> has larger particle size than Rev1, but both perform similarly in the <italic toggle="yes">in vitro</italic> growth curves and environmental susceptibility. <bold>(A)</bold> Bacterial growth curves determined by the number of viable cells (CFU/ml; the left axe, large symbols) and medium absorbance (OD<sub>600</sub>; the right axe, small symbols). <bold>(B)</bold> Particle size values measured by Zetasizer (&#956;m). Percentage of bacterial inhibition by: <bold>(C)</bold> Desiccation, <bold>(D)</bold> Detergents (0.1% Triton X-100), <bold>(E)</bold> Oxidative (H<sub>2</sub>O<sub>2</sub>), and <bold>(F)</bold> Acidic pH pressures, as models of stress encountered by <italic toggle="yes">Brucella</italic> in the natural environment and in the host niche. All results are expressed as the mean &#177; SD of at least three measures; strains Rev1, 16M, and 16M&#916;<italic toggle="yes">wzm</italic> were included as controls in all the experiments; the percentages of surviving bacteria (%) were determined with respect to the initial suspension. Fisher&#8217;s LSD test; <sup>***</sup><italic toggle="yes">p</italic> &#8804; 0.001, <sup>**</sup><italic toggle="yes">p</italic> &#8804; 0.01 vs. the indicated groups.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g007.jpg"/></fig></sec><sec id="S2.SS8"><title>Rev1&#916;<italic toggle="yes">wzm</italic> Is Attenuated in BeWo Cells and Safe in Pregnant Mice</title><p><italic toggle="yes">Brucella</italic> infection, including Rev1 (<xref rid="B58" ref-type="bibr">Jim&#233;nez de Bag&#252;&#233;s et al., 1989</xref>), targets the reproductive tract, starting in trophoblast giant cells, disseminating to placenta and fetuses and ending in spontaneous abortion. As preclinical models, we studied the ability of Rev1&#916;<italic toggle="yes">wzm</italic> to infect BeWo cells (a trophoblast-derived, choriocarcinoma cell line) and mouse placentas/fetuses as compared to the ability of Rev1. In BeWo cells, Rev1&#916;<italic toggle="yes">wzm</italic> was more adherent but was internalized less efficiently after adherence and replicated less than Rev1 (<xref rid="F8" ref-type="fig">Figure 8A</xref>). In turn, Rev1&#916;<italic toggle="yes">wzm</italic> was not found in mouse placentas/fetuses, even after inoculation at a 10-fold higher dose than Rev1, although both strains resulted in similar spleen infections (<xref rid="F8" ref-type="fig">Figure 8B</xref>). Histologically, Rev1&#916;<italic toggle="yes">wzm</italic> enabled normal placentas with minimal neutrophilic infiltration and normal fetus viability, differing from Rev1 by its marked macroscopic edema, destruction of placental epithelium, and leukocyte infiltration in yolk sac. This mouse model has been successfully used as screening of pathogenicity (<xref rid="B43" ref-type="bibr">Grill&#243; et al., 2012</xref>; <xref rid="B88" ref-type="bibr">Poveda-Urkixo et al., 2022</xref>), indicating that Rev1&#916;<italic toggle="yes">wzm</italic> might be safer than Rev1 in pregnant animals and justifying further experiments in the natural host.</p><fig position="float" id="F8" orientation="portrait"><label>FIGURE 8</label><caption><p>Rev1&#916;<italic toggle="yes">wzm</italic> is attenuated in BeWo cells, safe in pregnant mice, and induces minimal serological interference in ewes vaccinated at mid-pregnancy. <bold>(A)</bold> Adherence, internalization, and intracellular multiplication in BeWo cells (<italic toggle="yes">n</italic> = 3). <bold>(B)</bold> Bacteriology of spleens (upper panel), as well as macroscopic and microscopic representative images of placentas and fetuses from the pregnant CD1 mice, analyzed at 14 days after IP inoculation with 1 &#215; 10<sup>7</sup> CFU of Rev1&#916;<italic toggle="yes">wzm</italic> (<italic toggle="yes">n</italic> = 14; the right column) or 1 &#215; 10<sup>6</sup> CFU of Rev1 (<italic toggle="yes">n</italic> = 16; the left column). The arrow indicates leukocyte infiltration; scale bars = 100 &#956;m. Detection limit (log<sub>10</sub> 33 CFU/g tissue = 1.52) is indicated with a discontinuous line. In panels <bold>A,B</bold>, results are presented as mean &#177; SD of the correspondent n value. <bold>(C)</bold> Serological response (% reactors) in ewes vaccinated SC with 1.8 &#215; 10<sup>10</sup> CFU of Rev1&#916;<italic toggle="yes">wzm</italic> at mid-pregnancy, developing antibodies in ELISA-R/LPS and RBT. Fisher&#8217;s LSD or <italic toggle="yes">t</italic>-tests; <sup>***</sup><italic toggle="yes">p</italic> &#8804; 0.001, <sup>**</sup><italic toggle="yes">p</italic> &#8804; 0.01 vs. Rev1 control.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmicb-13-908495-g008.jpg"/></fig></sec><sec id="S2.SS9"><title>Rev1&#916;<italic toggle="yes">wzm</italic> Is Safe in Pregnant Ewes and Their Offsprings, and Induces Minimal Serological Interference</title><p>All ewes vaccinated with a high dose of Rev1&#916;<italic toggle="yes">wzm</italic> at mid-pregnancy (<italic toggle="yes">n</italic> = 6) showed normal clinical parameters, mild and transient local reactions at the inoculation site, with no shedding the mutant through vagina or milk, during pregnancy or lactation, and had normal parturitions at 144 &#177; 3.3 days of pregnancy. Likewise, at necropsy, the mutant was not found in any ewe or offspring. These results contrasted with those reported for Rev1 (i.e., shedding by vagina during pregnancy, bacteria in placentas at parturition and in milk, placental necrosis, abortions, and vertical transmission to lambs) (<xref rid="B58" ref-type="bibr">Jim&#233;nez de Bag&#252;&#233;s et al., 1989</xref>; <xref rid="B14" ref-type="bibr">Blasco, 1997</xref>; <xref rid="B52" ref-type="bibr">Hensel et al., 2020</xref>).</p><p>Serologically, all ewes reacted in ELISA-R/LPS after vaccination and turned negative before 8 weeks PI; a 66.7% also reacted in RBT (16.7% CFT positive), a percentage that decreased progressively until turning all ewes negative before 5 weeks PI (<xref rid="F8" ref-type="fig">Figure 8C</xref>). These reactions were significantly less interferent than those reported for Rev1 (<xref rid="B11" ref-type="bibr">Barrio et al., 2009</xref>).</p></sec><sec id="S2.SS10"><title>The Impact of the Rev1 Background on Rev1&#916;<italic toggle="yes">wzm</italic> Vaccine Properties Was Unpredictable</title><p>It is commonly assumed that vaccine candidates should retain some residual virulence to be efficient (<xref rid="B44" ref-type="bibr">Grill&#243; et al., 2000</xref>). Indeed, just those 16M <italic toggle="yes">wzm</italic> mutants that show an attenuation pattern similar to Rev1 are as protective as Rev1 against a <italic toggle="yes">B. melitensis</italic> virulent challenge (<xref rid="B127" ref-type="bibr">Zabalza Barangu&#225;, 2017</xref>), while 16M&#916;<italic toggle="yes">wzt</italic> is less persistent and less protective than Rev1 (<xref rid="B122" ref-type="bibr">Wang Z. et al., 2014</xref>). On this basis, the high attenuation of Rev1&#916;<italic toggle="yes">wzm</italic> should have led to failed efficacy; however, and, unpredictably, Rev1&#916;<italic toggle="yes">wzm</italic> (but not Rev1&#916;<italic toggle="yes">wzt</italic>) triggered a splenomegaly associated with a particular Th1 cytokine balance, as well as to a protective efficacy against virulent challenges. Besides the genetic and phenotypic divergences described between the Rev1 and 16M parentals related to virulence attenuation (<xref rid="B54" ref-type="bibr">Issa and Ashhab, 2016</xref>; <xref rid="B97" ref-type="bibr">Salmon-Divon et al., 2018</xref>, <xref rid="B98" ref-type="bibr">2019</xref>; <xref rid="B63" ref-type="bibr">Kornspan et al., 2020</xref>), we have now described additional differences in genetic transcription, antigenicity evidenced by Western blot, and susceptibility to antibiotics and environmental stress factors. Indeed, when <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutations were applied to other brucellae (<xref rid="B120" ref-type="bibr">Wang et al., 2014a</xref>; <xref rid="B47" ref-type="bibr">Grill&#243; et al., 2017</xref>; <xref rid="B5" ref-type="bibr">Arag&#243;n-Aranda et al., 2020</xref>; <xref rid="B66" ref-type="bibr">Lalsiamthara et al., 2020</xref>), neither mutant was as immunogenic as Rev1&#916;<italic toggle="yes">wzm</italic>. All these findings demonstrate the relevance of the background in vaccine properties, as well as the unpredictable efficacy results obtained with Rev1&#916;<italic toggle="yes">wzm</italic>.</p></sec></sec><sec sec-type="conclusion" id="S3"><title>Conclusion</title><p>The Wzm/Wzt system is broadly conserved among gram-negative bacteria, and its inactivation in Rev1 not only restrains the export, quantity, and availability of O-PS but also triggers phenotypic changes of the OM and cell wall. Despite similarities <italic toggle="yes">in vitro</italic>, deletion of Wzm or Wzt transporter moieties elicited different immune responses and efficacies against <italic toggle="yes">Brucella</italic>-virulent infections. Indeed, Rev1&#916;<italic toggle="yes">wzm</italic> displays superior vaccine properties: attenuation, immunogenicity, efficacy against a virulent infection in mice, safety in pregnant mice, high susceptibility to diverse stresses and antimicrobials, and safety and minimal serological interference in pregnant ewes. These results (summarized in <xref rid="FS2" ref-type="supplementary-material">Supplementary Figure 2</xref>) thus highlight a new concept that is essential in vaccine development, i.e., that a low persistence is not at odds with efficacy.</p></sec><sec sec-type="materials|methods" id="S4"><title>Materials and Methods</title><sec id="S4.SS1"><title>Strains and Culture Conditions</title><p>Bacterial strains (<xref rid="TS1" ref-type="supplementary-material">Supplementary Table 1</xref>) were stored at &#8211;20&#176;C in 10% skimmed milk with 3% lactose (PanReac AppliChem, Castellar del Vall&#233;s, Barcelona, Spain) and routinely cultured at 37&#176;C in normal atmosphere (air), using Trypticase Soy Broth (TSB; Condalab) at 150 rpm, or in plates of TSB supplemented with 1.5% bacteriological agar (TSA; Pronadisa) for <italic toggle="yes">Escherichia coli</italic> strains, or Blood Agar Base No. 2 (BAB; Oxoid) for <italic toggle="yes">Brucella</italic> spp., either plain or supplemented with 5% newborn calf serum (S; Gibco), 5% sucrose (Suc<sub>5</sub>; VWR Chemicals, Radnor, PA, United States), and/or antibiotics (Sigma-Aldrich, San Luis, MO, United States), such as kanamycin (50 &#956;g/ml; Km<sub>50</sub>), polymyxin B (1.5 &#956;g/ml; PxB<sub>1</sub>.<sub>5</sub>), colistin (4 &#956;g/ml; Col<sub>4</sub>), gentamycin (15 &#956;g/ml; Gm<sub>15</sub>), streptomycin (2.5 &#956;g/ml; Str<sub>2</sub>.<sub>5</sub>), doxycycline (0.02 &#956;g/ml; Dx<sub>0</sub>.<sub>02</sub>), rifampicin (0.4 &#956;g/ml; Rf<sub>0</sub>.<sub>4</sub>), and penicillin G at (5 IU/ml; P<sub>5</sub>) or (0.5 IU/ml; P<sub>0</sub>.<sub>5</sub>), as needed. Suspensions were adjusted by spectrophotometry (SmartSpec Plus; Bio-Rad, Hercules, CA, United States) in sterile TSB or PBS (pH, 7.2; VWR Chemicals, Radnor, PA, United States), as described elsewhere (<xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>). The exact number of viable counts was determined retrospectively by serial dilutions in PBS and plating (0.1 ml, done in triplicate).</p></sec><sec id="S4.SS2"><title>Sequence Analysis and DNA Manipulation</title><p><italic toggle="yes">In silico</italic> studies were performed with BLAST (<xref rid="B2" ref-type="bibr">Altschul et al., 1990</xref>), NCBI (<xref rid="B100" ref-type="bibr">Sayers et al., 2022</xref>), and KEGG (<xref rid="B61" ref-type="bibr">Kanehisa and Goto, 2000</xref>) databases. PCR primers (<xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>) were synthesized by Sigma-Aldrich Qu&#237;mica SL (Madrid, Spain). Vector sequences were obtained from Addgene (<xref rid="B60" ref-type="bibr">Kamens, 2015</xref>). Vector or chromosomal DNA purifications were performed by <italic toggle="yes">miniprep</italic> with E.Z.N.A. Plasmid Mini Kit I (Omega Bio-tek, Norcross, Georgia) or DNeasyUltraClean Microbial Kit (Qiagen, D&#252;sseldorf, Germany). Single-colony DNA was extracted by boiling and centrifugation. PCR products were purified using the ATP Gel/PCR DNA Fragment Extraction Kit (ATP Biotech Inc., Taipei, China). DNA was quantified with a NanoDrop Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, United States) and sequenced by STAB VIDA (Caparica, Portugal).</p></sec><sec id="S4.SS3"><title>Construction and Complementation of Single and Double <italic toggle="yes">wzm/wzt</italic> Rev1 Mutants</title><p>In-frame deletion mutants were obtained as previously described (<xref rid="B25" ref-type="bibr">Conde-&#193;lvarez et al., 2012</xref>), using the suicide plasmids pJQKm&#916;<italic toggle="yes">wzm</italic> (<xref rid="B127" ref-type="bibr">Zabalza Barangu&#225;, 2017</xref>) and/or pJQKm&#916;<italic toggle="yes">wzt</italic>. The latter was constructed using 16M genomic DNA and the designed primers (<xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>) to amplify 198 bp upstream and <italic toggle="yes">wzt</italic> 1-66 codons with F1-R2, and <italic toggle="yes">wzt</italic> 209&#8211;253 codons and 193 bp downstream with F3-R4 <italic toggle="yes">wzt</italic>. These fragments were fused by overlap PCR with F1-R4 <italic toggle="yes">wzt</italic>, cloned in pCR2.1 (TOPO<sup>&#174;</sup>TA Cloning, ThermoFisher Scientific) and sequenced. After using pCR2.1&#916;<italic toggle="yes">wzt</italic> to transform <italic toggle="yes">E. coli</italic> TOP10F&#8217;, &#916;<italic toggle="yes">wzt</italic> was subcloned into pJQKm (<xref rid="B89" ref-type="bibr">Quandt and Hynes, 1993</xref>; <xref rid="B105" ref-type="bibr">Scupham and Triplett, 1997</xref>) <italic toggle="yes">Bam</italic>HI and <italic toggle="yes">Xba</italic>I sites. Clones were screened by PCR (<xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>), and representative non-mutated (NM) ones from each mutagenesis were kept as controls. For complementation, transconjugants, including the pSRK vector with <italic toggle="yes">wzm</italic> (<xref rid="B127" ref-type="bibr">Zabalza Barangu&#225;, 2017</xref>), <italic toggle="yes">wzt</italic> or <italic toggle="yes">wzm-wzt</italic> (subcloning of BMEI1415 or BMEI1415-BMEI1416 into <italic toggle="yes">Spe</italic>I and <italic toggle="yes">Xho</italic>I sites) were selected in Km<sub>50</sub> plates and, for pSRK<italic toggle="yes">wzm-wzt</italic>, 0.1-mM IPTG (Invitrogen, Waltham, MA, United States), and checked by PCR.</p></sec><sec id="S4.SS4"><title>Transcriptional Analysis</title><p>Genetic expression was analyzed from five independent extractions of Rev1 and derivatives, or 2 of 16M and 16M&#916;<italic toggle="yes">wzm</italic> for comparative purposes. Total RNA from exponential cultures was extracted by lysozyme (Sigma-Aldrich, San Luis, MO, United States), proteinase K (Merck, Darmstadt, Germany), Zwittergent (Merck, Darmstadt, Germany), RNeasy Mini kit (Qiagen, D&#252;sseldorf, Germany), and DNase [Ambion, Austin, TX, United states (ThermoFisher)] treatments, and its quality checked with Gel Loading Buffer II [Ambion, Austin, TX, United states (ThermoFisher)], in an agarose gel by confirming that the intensity ratio of 23S:16S proteins was 2:1, obtaining the cDNA with PrimeScript RT kit (Takara, Saint-Germain-en-Laye, France). The qRT-PCR was performed with SYBR Premix Ex Taq (Takara, Saint-Germain-en-Laye, France) in duplicate in an AriaMx real-time PCR system (Agilent) using 96-well microplates (Axygen, New York, NY, United States) as follows: 10 min at 95&#176;C, 45 cycles of 15 s at 95&#176;C, and 1 min at 60&#176;C. Primers (<xref rid="TS4" ref-type="supplementary-material">Supplementary Table 4</xref>) efficiency (0.9&#8211;1.1) was assessed as 10<sup>(&#8211;1/slope<italic toggle="yes">ofCtvs</italic>.<italic toggle="yes">DNAdilutions</italic>)</sup>&#8211;1. Data were analyzed with Agilent AriaMx v. 1.2 software (Santa Clara, CA, United States) and relative transcription normalized by the 2<sup>&#8211;&#916;&#916;Ct</sup> method using <italic toggle="yes">IF-1</italic> gene and representing the fold-change over Rev1 or 16M controls.</p></sec><sec id="S4.SS5"><title>Characterization of Rev1 <italic toggle="yes">wzm/wzt</italic> Mutants</title><p>Conventional <italic toggle="yes">Brucella</italic> biotyping was performed following the standard protocols (<xref rid="B1" ref-type="bibr">Alton et al., 1988</xref>). Briefly, the mutants were submitted to tests of catalase, oxidase, urease, agglutination with acriflavine, agglutination with anti-A/anti-M/anti-R monospecific sera, lysis by bacteriophages Tb, Wb, Iz, and R/C, susceptibility to thionine, fuchsine, and safranin O dyes. Also, we analyzed purity and homogeneity of colony size and the LPS phase by the crystal violet-oxalate test (<xref rid="B44" ref-type="bibr">Grill&#243; et al., 2000</xref>). The <italic toggle="yes">in vitro</italic> growth curves were assessed by duplicate as turbidity and CFU/ml from suspensions adjusted to OD<sub>600</sub> = 0.1 (TSB, 37&#176;C, 150 rpm) at the selected intervals.</p><p>MIC/MBC<sub>90</sub> to the selected antibiotics were determined in the cation-adjusted M&#252;ller&#8211;Hinton medium (M-H; BD) by the standard broth microdilutions method (<xref rid="B34" ref-type="bibr">EUCAST: European Committee for Antimicrobial Susceptibility Testing, 2003</xref>), using Rev1 and <italic toggle="yes">E. coli</italic> K12 as controls. Susceptibility to Dx<sub>0</sub>.<sub>02</sub>, Gm<sub>0</sub>.<sub>125</sub>, Rf<sub>0</sub>.<sub>4</sub>, Str<sub>2</sub>.<sub>5</sub>, PxB<sub>1</sub>.<sub>5</sub>, Col<sub>4</sub>, P<sub>0</sub>.<sub>5</sub>, and Saf<sub>50</sub> was quantified by seeding suspensions between 10<sup>9</sup> and 10<sup>4</sup> CFU/ml by triplicate in BAB or BAB-S plates incubated (37&#176;C, 8 days) under normal air or 10% CO<sub>2</sub> atmosphere. Results were expressed as the% of bacterial survival vs. the standard culture (BAB, air). Resistance to vancomycin (Sigma-Aldrich, San Luis, MO, United States) was determined by incubating a suspension of 10<sup>4</sup> CFU/ml in PBS with twofold serial dilutions (50&#8211;3.125 mg/ml) of the antibiotic (37&#176;C, 1 h, 100 &#956;L each, by duplicate) and plating in BAB to determine the% of surviving bacteria vs. control.</p><p>Analyses of the R-LPS and internal O-PS were performed with &#8776;10<sup>10</sup> CFU/ml of whole bacteria inactivated by 0.5% phenol (72 h, 37&#176;C, 150 rpm) or purified LPS by an extraction kit (Intron Biotechnology, Seongnam, South Korea&#8217;s) in SDS-PAGE and further modified periodate-alkaline silver staining or WB (<xref rid="B114" ref-type="bibr">Tsai and Frasch, 1982</xref>; <xref rid="B74" ref-type="bibr">Monreal et al., 2003</xref>). The latter was revealed with primary antibodies: (i) mAbs (1:2,000) anti-C/Y 33H8 or 42D2 (batch No. 051119 or 300502, Ingenasa), (ii) anti-M monospecific polyclonal rabbit serum (1:100; IdAB collection), or (iii) anti- <italic toggle="yes">B. ovis</italic>, Rev1, Rev1&#916;<italic toggle="yes">wzm</italic> (either normal or heat treated 1 h, 56&#176;C) or 16M&#916;<italic toggle="yes">wzm</italic> sera from sheep experimentally infected (1:400; IdAB collection); and secondary HRP-conjugated antibodies: (i) an anti-mouse at 1:3,000 (Bio-Rad, Hercules, CA, United States cat. No. 170-6516), (ii) an anti-rabbit at 1:2,500 (Bio-Rad, Hercules, CA, United States cat. No. 170-6515), or (iii) protein G at 1:1,000 (Pierce cat. No. 21193), all diluted in 1% milk PBST. The images were acquired with ECL Kit (Bio-Rad, Hercules, CA, United States) in a ChemiDocSyngene with GeneSnap 7 (Frederick, MD, United States) or Bio-Rad with Quantity One (Hercules, CA, United States) software. Brightness and contrast adjustments were applied uniformly using GNU Image Manipulation Program v. 2.10 (open source<sup><xref rid="footnote2" ref-type="fn">2</xref></sup>).</p><p>To assess the lack of spontaneous mechanisms of dissociation described for Rev1 (<xref rid="B70" ref-type="bibr">Mancilla et al., 2013</xref>), the integrity of GI-2 and <italic toggle="yes">wbk</italic> regions was determined after serial subcultures in BAB under normal or 10% CO<sub>2</sub> atmospheres by conventional PCR with the primers presented in <xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>; the amplified products were 353 bp (P1&#8211;P3) and 1,016 bp (P5&#8211;P7) in case of gene integrity, or 586 bp (P1&#8211;P2) and &#8776;1,400 bp (P5&#8211;P6) in case of excision.</p></sec><sec id="S4.SS6"><title>Study of Envelope-Related Properties</title><p>Autoagglutination was assessed by OD<sub>600</sub> readings as described (<xref rid="B20" ref-type="bibr">Caro-Hern&#225;ndez et al., 2007</xref>) in at least two independent experiments. Bacterial particle size and surface charge of phenol-inactivated bacteria (37&#176;C, 150 rpm, 24 h) adjusted to OD<sub>600</sub> = 0.2 (7,000 &#215; <italic toggle="yes">g</italic>, 4&#176;C, 15 min) were measured in CsCl/HEPES as elsewhere (<xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>) in absence or presence of poly-L-lysine (P6516; Sigma-Aldrich, San Luis, MO, United States) in a Zetasizer Ultra (Malvern Panalytical, Malvern, United Kingdom) at 25&#176;C, using the ZS-XPLORER v. 2.01 software (United Kingdom).</p><p>Hydrophobicity was determined by measuring bacterial adherence, using a hydrocarbons method (<xref rid="B92" ref-type="bibr">Rosenberg et al., 1980</xref>), modified to avoid cell degradation due to xylene toxicity (<xref rid="B28" ref-type="bibr">Czerwonka et al., 2016</xref>). Phenol-inactivated cultures were centrifuged (6,000 &#215; <italic toggle="yes">g</italic>, 4&#176;C, 10 min) and washed with a PUM buffer; then, 2 mL adjusted to OD<sub>470</sub> = 1 was mixed with an equal volume of xylene (PanReac AppliChem, Castellar del Vall&#233;s, Barcelona, Spain) by triplicate. After a vortex (5 s)-incubation (37&#176;C, 10 min)-vortex (30 s)-incubation (room temperature; RT, 2 h) step, the absorbance of the low phase was measured to determine the hydrophobicity index as: 1 &#8211; (OD<sub>470</sub>/1).</p><p>Biofilm formation was studied by bacterial adhesion to polystyrene, cellular viability, and Calcofluor and Congo Red assays. Briefly, 200 &#956;L with 5 &#215; 10<sup>8</sup> CFU/ml in TSB was incubated (37&#176;C, 3 weeks) in 96-well plates (Sarstedt) by triplicate and, after PBS washings, was stained with crystal violet (PanReac AppliChem, Castellar del Vall&#233;s, Barcelona, Spain; 0.05% in water, RT, 15 min). The stain was washed with distilled water and dissolved in ethanol (Merck, Darmstadt, Germany) to measure adhesion as OD<sub>600</sub>. The viability of the attached bacteria was assessed by swabbing and culturing in BAB. EPS production was evaluated by seeding 20 &#956;L of 10<sup>9</sup> CFU/ml in BAB with 0.1% Calcofluor White M2R (Sigma-Aldrich, San Luis, MO, United States) or 4% Congo Red (Merck, Darmstadt, Germany); after 3 weeks, at 37&#176;C, the intensity of Calcofluor&#8217;s fluorescence measured in a UV transilluminator (UVP) and color shift to intense red/black were visualized and quantified with ImageJ/Fiji v. 2.1 software (<xref rid="B101" ref-type="bibr">Schindelin et al., 2012</xref>).</p><p>The osmotic resistance was studied by incubating (37&#176;C, 48 h) 10<sup>4</sup> CFU/ml in TSB: water (1:5; hypoosmotic) or in 0.5 M NaCl (<xref rid="B32" ref-type="bibr">Dong et al., 2015</xref>) or 0.34-M Suc (<xref rid="B93" ref-type="bibr">Roset et al., 2006</xref>) (VWR Chemicals, Radnor, PA, United States; hyperosmotic) by triplicate. The CFU/ml was determined in BAB to calculate the % of bacterial survival vs. the initial suspension in two independent experiments.</p></sec><sec id="S4.SS7"><title>Susceptibility to Environmental Factors</title><p>Tolerance to desiccation was studied by keeping (RT, 6 days) a suspension (200 &#956;L/well, 10<sup>9</sup>CFU/ml, TSB) completely dried by evaporation into 12-well plates (Sarstedt) by triplicate and rehydrating the pellet in PBS to determine the viable CFU/ml in BAB. Susceptibility to detergents was firstly evaluated with SDS (Merck, Darmstadt, Germany), since this surfactant inactivated all the <italic toggle="yes">Brucella</italic> tested at 0.06%; bacterial suspensions (10<sup>4</sup>CFU/ml, 100 &#956;L, by triplicate) were cultured in BAB with 0.1% Triton X-100 (Sigma-Aldrich, San Luis, MO, United States). Oxidative stress and acid pH resistances were analyzed by incubating (37&#176;C, 1 h) a 10<sup>4</sup> CFU/ml suspension in TSB with an equal volume (100 &#956;L) of H<sub>2</sub>O<sub>2</sub> at increasing concentrations up to 5 mM or with acidified TSB at a final pH from 7.3 to 2.3 by duplicate. Results were expressed as bacteria (%) vs. control.</p></sec><sec id="S4.SS8"><title>Transmission Electron Microscopy</title><p>Massive <italic toggle="yes">Brucella</italic> cultures (37&#176;C, 24 h) were harvested, washed (7,000 &#215; <italic toggle="yes">g</italic>, 10 min) two times with sterile Sorenson&#8217;s phosphate buffer pH 7.4 (<xref rid="B65" ref-type="bibr">Kuo, 2007</xref>) and fixed (4&#176;C, overnight) with 2.5% glutaraldehyde (Grade I, 70%; Sigma-Aldrich San, Luis, MO, United States) and 2% paraformaldehyde (powder, Sigma-Aldrich, San Luis, MO, United States) in a buffer. Samples were adsorbed (1:200 dilution, 3 &#956;L, 1 min) in hydrophilized carbon-coated copper grids (glow discharge 5 mA, 20 s, Leica EM ACE200). After negative staining (1% uranyl acetate, 10 s, two times), representative images were acquired (JEOL JEM 1400 Plus).</p></sec><sec id="S4.SS9"><title>Ultra-Performance Liquid Chromatography-Mass Spectrometry</title><p>Peptidoglycan was purified from three biological replicas normalized to OD<sub>600</sub> = 1 and analyzed, using 16M as control, as described elsewhere (<xref rid="B30" ref-type="bibr">Desmarais et al., 2013</xref>; <xref rid="B4" ref-type="bibr">Alvarez et al., 2016</xref>, <xref rid="B3" ref-type="bibr">2020</xref>) on a Waters UPLC system (Waters Corporation, Milford, MA, United States) equipped with an ACQUITY UPLC BEH C18 Column, 130 &#197;, 1.7 &#956;m, 2.1 mm &#215; 150 mm (Waters, United States) and a dual wavelength absorbance detector. Muropeptide identity was confirmed by MS/MS analysis, using Xevo G2-XS QT of system (Waters Corporation, Milford, MA, United States). Quantification of muropeptides was based on their relative abundances normalized to the total amount of PG. Unidentified muropeptides and minor peaks with a relative abundance lower than 0.5% were excluded from further analysis.</p></sec><sec id="S4.SS10"><title>Susceptibility to Soluble Factors of the Immune System</title><p>Susceptibility to polymyxins B and E (colistin) as a model of cationic peptides and to normal ovine serum (IdAB collection) as a source of complement after 18 h of incubation was determined by duplicate as reported (<xref rid="B71" ref-type="bibr">Mart&#237;nez de Tejada et al., 1995</xref>; <xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>). Likewise, the <italic toggle="yes">in vitro</italic> bacterial killing properties of serum from sheep immunized with Rev1&#916;<italic toggle="yes">wzm</italic> (IdAB collection) were studied against <italic toggle="yes">B. melitensis</italic> 16M (S-LPS) or <italic toggle="yes">B. ovis</italic> PA (R-LPS) virulent strains; normal sheep serum and PBS or PBS-S for <italic toggle="yes">B. ovis</italic> PA were used as controls to determine survival (%) in two independent experiments.</p></sec><sec id="S4.SS11"><title>BeWo Cells Studies</title><p>Bacterial adhesion, internalization, and intracellular multiplication in the BeWo (ATCC CCL-98; Sigma-Aldrich, San Luis, MO, United States) trophoblast-like cell line were determined as described previously (<xref rid="B21" ref-type="bibr">Casta&#241;eda-Rold&#225;n et al., 2004</xref>; <xref rid="B96" ref-type="bibr">Salcedo et al., 2013</xref>; <xref rid="B88" ref-type="bibr">Poveda-Urkixo et al., 2022</xref>). Briefly, 5 &#215; 10<sup>4</sup> cells/well were cultured in 12-well microtiter plates (Sarstedt) with an enriched F-12K medium (Kaighn&#8217;s Modification) supplemented with 10% of inactivated FBS and 2-mM L-glutamine (Glutamax 100&#215;) (Gibco). The cells were infected at an MOI of 100, and, after 30 min of incubation, the adhered bacteria were killed with Gm<sub>50</sub> (1.5-h exposure). After cells lysis with 0.1% Triton X-100 (Sigma-Aldrich, San Luis, MO, United States), the number of CFU/ml was determined in both treated (intracellular) and untreated (total) wells by plating in BAB to calculate (i) adhesion as log<sub>10</sub> CFU/ml = total CFU-intracellular CFU; (ii)% of internalization = (intracellular CFU/total CFU) &#215; 100; and (iii) intracellular multiplication as log<sub>10</sub> CFU/ml found at 2, 24, and 48 h.</p></sec><sec id="S4.SS12"><title>Animal Experiments</title><sec id="S4.SS12.SSS1"><title>Biosafety and Ethics Statements</title><p><italic toggle="yes">Brucella</italic> and GMOs were used in the registered BSL3 facilities (code A/ES/15/I-05) of the Instituto de Agrobiotecnologi&#236;a (IdAB), previous authorization of the Spanish Consejo Interministerial de Organismos Modificados Gen&#233;ticamente (CIOMG) (A/ES/16/39). BALB/c 7-week-old female or CD1 4-week-old male and female mice were purchased from Charles River (Elbeuf, France) and accommodated for 2 weeks in the authorized IdAB animal facilities (ES/31-2016-000002-CR-SU-US) before experimental proceedings. The animals were kept in biosafety cages with water and food <italic toggle="yes">ad libitum</italic> and manipulations carried out following FELASA (<xref rid="B90" ref-type="bibr">Rehbinder et al., 2000</xref>) and ARRIVE (<xref rid="B82" ref-type="bibr">Percie du Sert et al., 2020</xref>) guidelines. Procedures were based on brucellosis standards (<xref rid="B43" ref-type="bibr">Grill&#243; et al., 2012</xref>) and authorized by Gobierno de Navarra (PI-025-14) in compliance with the current Spanish (RD 53/2013; ECC/566/2015) and European (Directive UE 2010/63) legislations. Churra ewes were purchased from <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. ovis</italic> free herds of Castilla y Le&#243;n, Spain, and kept in the authorized BSL2 and BSL3 facilities of the Universidad Complutense de Madrid (UCM; ES/281200000147 and ES/280790000154). Before starting the experiment, all ewes were serologically assessed as free from the main reproductive infections (i.e., <italic toggle="yes">Chlamydia abortus</italic>, <italic toggle="yes">Coxiellaburnetii</italic>, <italic toggle="yes">Salmonella</italic> Abortusovis, <italic toggle="yes">Toxoplama gondii</italic>, and Maedi-Visna). The GMOs and animal experiments were evaluated by the ethics and biosecurity committee of UCM [OH (CEA)-UCM-32-2018], CIOMG (B/ES/18/31; A/ES/20/83), and Agencia Espa&#241;ola de Medicamentos y Productos Sanitarios (AEMPS; 194/PIV and 432/ECV). Eventual authorizations were granted by Gobierno de la Comunidad de Madrid (PROEX 187/18). Note that the use of <italic toggle="yes">Brucella</italic> Gm<sup>R</sup> strains is no longer under restricted use since 2014, as it does not compromise the control of disease in humans or animals (<xref rid="B108" ref-type="bibr">Smith et al., 2015</xref>).</p></sec><sec id="S4.SS12.SSS2"><title>Spleen Infection and Cytokine Profiles in Mice</title><p>In general, the mice were inoculated IP or SC with 0.1 ml of bacterial suspension and killed by cervical dislocation at selected intervals to determine the number of viable CFU/spleen (expressed as log<sub>10</sub> CFU/spleen), and the spleens weight (grams/spleen), as reported (<xref rid="B45" ref-type="bibr">Grill&#243; et al., 2006b</xref>). The mice inoculated with Rev1 in standard conditions (10<sup>5</sup> CFU, IP or SC) or with PBS were used as controls.</p><p>A dose-response experiment was performed in the BALB/c mice inoculated IP with 10<sup>5</sup>, 10<sup>6</sup>, 10<sup>7</sup> or 10<sup>8</sup> CFU/mouse of Rev1&#916;<italic toggle="yes">wzm</italic>, and the spleen counts/weights (<italic toggle="yes">n</italic> = 5) were determined at 2 weeks PI. Thereafter, with the two selected doses (10<sup>6</sup> and 10<sup>8</sup> CFU/mouse), we performed an experiment of persistence by determining the spleen counts and weights at 1, 2, 4, and/or 6 weeks PI.</p><p>For the three mutants, the kinetics of infection, weights, and cytokines in spleens were studied in groups of 14 BALB/c mice IP, inoculated with 10<sup>8</sup> CFU/animal (selected as optimal dose) and weekly killed (<italic toggle="yes">n</italic> = 3 at 1 and 4 weeks PI; <italic toggle="yes">n</italic> = 4 at 2 and 3 weeks PI). For cytokines, individual supernatants were obtained (1,000 &#215; <italic toggle="yes">g</italic>, 10 min) in Hanks balanced salt solution (Gibco) treated (1 h, 4&#176;C) with 1% CHAPS (Sigma-Aldrich, San Luis, MO, United States) and filtrated (0.20 &#956;m, Millipore). Moreover, blood samples were collected at 2, 6, and 24 h PI (<italic toggle="yes">n</italic> = 5) by retro-orbital plexus puncture in mice anesthetized (ISOFLO, Ecuphar) and processed as a pool (by mixing equal volume of serum from each mouse) by analyzing each pool in duplicate; Rev1&#916;<italic toggle="yes">wzm</italic>, Rev1, and PBS groups (<italic toggle="yes">n</italic> = 5) were analyzed in two independent experiments. Similarly, the blood samples were obtained one time a week directly prior to each necropsy and processed individually (<italic toggle="yes">n</italic> = 5). Sera samples and splenocytes supernatants were used to determine IL-6, IL-12p40, TNF-&#945;, and IFN-&#947; using commercial ELISA kits (BD OptEIA) in two technical replicates/sample. The results were expressed as pg/spleen and pg/ml of serum.</p><p>The <italic toggle="yes">in vivo</italic> stability of Rev1&#916;<italic toggle="yes">wzm</italic> was evaluated after 5 serial passages in the mice (<xref rid="B102" ref-type="bibr">Schurig et al., 1991</xref>). Groups of 3 CD1 mice were inoculated IP at 10<sup>8</sup> CFU/animal and necropsied at 3 days PI to determine the CFU/spleens. The bacteria recovered in each passage were subcultured to prepare the inocula of the next one. The genetic and phenotypic stability of the bacteria recovered from the last passage was assessed as described for the <italic toggle="yes">in vitro</italic> stability.</p></sec><sec id="S4.SS12.SSS3"><title>Vaccine Efficacy Studies</title><p>The efficacy of Rev1 <italic toggle="yes">wzm</italic>/<italic toggle="yes">wzt</italic> mutants to protect against <italic toggle="yes">B. melitensis</italic> or <italic toggle="yes">B. ovis</italic> virulent infections was analyzed in the BALB/c mice (<italic toggle="yes">n</italic> = 5), as reported (<xref rid="B42" ref-type="bibr">Gonz&#225;lez et al., 2008</xref>; <xref rid="B110" ref-type="bibr">Soler-Llor&#233;ns et al., 2014</xref>). The mice (<italic toggle="yes">n</italic> = 5) were vaccinated IP or SC with 10<sup>8</sup> CFU of the mutant and, 4 weeks later, were challenged IP with 10<sup>4</sup> CFU of <italic toggle="yes">B. melitensis</italic> H38:Gm or with 5 &#215; 10<sup>5</sup> CFU of <italic toggle="yes">B. ovis</italic> PA:Gm. Additional groups (<italic toggle="yes">n</italic> = 5) of Rev1 in standard conditions (10<sup>5</sup> CFU/animal, SC) and PBS were included as controls. The log<sub>10</sub> CFU/spleen of the challenge strain was determined in BAB-Gm<sub>15</sub>, or in BAB-S-Gm<sub>15</sub> with incubation in 10% CO<sub>2</sub> at 2 or 3 weeks after challenging with H38 or <italic toggle="yes">B. ovis</italic> PA, respectively.</p></sec><sec id="S4.SS12.SSS4"><title>Safety in Pregnant Mice</title><p>Pregnancies were synchronized in the CD1 mice by light/darkness control and naturally mating for 2 days. On the day of pregnancy 4.5 &#177; 1, the mice were inoculated IP with 1 &#215; 10<sup>7</sup> CFU/mouse of Rev1&#916;<italic toggle="yes">wzm</italic> (<italic toggle="yes">n</italic> = 14), or 1 &#215; 10<sup>6</sup>CFU/mouse of Rev1 (<italic toggle="yes">n</italic> = 16) as control; 14 days later, all were necropsied to individually collect spleens, placentas, and fetuses. The CFU/g was determined by plating serial 10-fold PBS dilutions in BAB, applying external ethanol to avoid fetus-placenta cross contamination. For histopathological studies, placental tissues were fixed with 10% neutral buffered formaldehyde and stained with hematoxylin-eosin (H-E) (PanReac AppliChem, Castellar del Vall&#233;s, Barcelona, Spain).</p></sec><sec id="S4.SS12.SSS5"><title>Safety in Pregnant Ewes</title><p>Churra ewes (<italic toggle="yes">n</italic> = 6) were SC vaccinated on the day of gestation 75 &#177; 2 (DG75) with 1.8 &#215; 10<sup>10</sup> CFU of Rev1&#916;<italic toggle="yes">wzm</italic>, including a PBS group of pregnant ewes (<italic toggle="yes">n</italic> = 4) as control. Clinical symptoms, rectal temperature, and local reactions were assessed during the first 2 weeks PI. Vaginal shedding was weekly monitored along the pregnancy by double-swab sampling and at parturition by collecting cotyledons and milk. The swabs were analyzed by (i) direct DNA extract and qRT-PCR of the IS<italic toggle="yes">711</italic> (<xref rid="B84" ref-type="bibr">P&#233;rez-Sancho et al., 2013</xref>) and (ii) duplicate culturing in a CITA-selective medium (<xref rid="B29" ref-type="bibr">De Miguel et al., 2011</xref>) standard or modified by halving vancomycin and colistin concentrations, and incubation at 37&#176;C for 7&#8211;14 days; presumptive colonies were confirmed by over-colony PCR with F1-R4<italic toggle="yes">wzm</italic> (<xref rid="TS2" ref-type="supplementary-material">Supplementary Table 2</xref>). Cotyledons homogenized in sterile PBS (1:10, w:v) and the milk samples were cultured (1 ml/plate) in these media. Within 4 weeks after delivery, all ewes and lambs were necropsied to determine bacterial presence in organs (spleen, liver, uterus, and mammary gland) and lymph nodes (pre-scapular, parotid, retropharyngeal, submaxillary, crural, iliac, and supra-mammary) by homogenization. Serological responses were weekly monitored in serum by an INgezim <italic toggle="yes">B. ovis</italic> kit (ELISA-R/LPS; Ingenasa), standard Rose Bengal test (RBT), and those reacting in RBT by S-LPS Complement Fixation test (CFT) at the officially accredited Laboratorio de Calidad Agroalimentaria de Navarra (Villava, Navarra, Spain), as recommended (<xref rid="B81" ref-type="bibr">OIE, 2018</xref>).</p></sec></sec><sec id="S4.SS13"><title>Statistical Analysis</title><p>Statistical analysis and graphical representations were performed with GraphPad Prism 8 software (Inc., San Diego, CA, United States). <italic toggle="yes">P</italic>-values were determined by unpaired two-tailed Student&#8217;s <italic toggle="yes">t</italic>-test or by one- or two-way ANOVA, followed by Fisher&#8217;s least significant difference (LSD) test, with 95% confidence intervals, according to data classification. For PG analysis, only variations higher than 10% were considered as significant. The final figures were assembled using Adobe Illustrator 2020 (San Jos&#233;, CA, United States).</p></sec></sec><sec sec-type="data-availability" id="S5"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="FS1" ref-type="supplementary-material">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p></sec><sec id="S6"><title>Ethics Statement</title><p>Mice studies were reviewed and approved by Comit&#233; de &#201;tica, Experimentaci&#243;n Animal y Bioseguridad (CEEAB) of Public University of Navarra (UPNA), Comit&#233; de &#201;tica of CSIC, and the competent authority of Navarra Government; and sheep experiments were approved by the Ethics and Biosecurity Committee of Universidad Complutense de Madrid (UCM) and the competent authority of Comunidad de Madrid.</p></sec><sec id="S7"><title>Author Contributions</title><p>MG conceived, led, and supervised the study. SM-B designed and performed experiments. IP-U performed experiments in cells and pregnant mice. SM-B and MG carried out other mice experiments, and wrote the draft and the final manuscript. SM-B, IP-U, and MG participated in the sheep assay. SM-B, AZ-B, and LP contributed to mutants&#8217; construction and to design some <italic toggle="yes">in vitro</italic> experiments. OI and FC performed UPLC-MS, and analyzed and discussed the results. SM-B, IP-U, AZ-B, and MG analyzed, discussed, and interpreted all results. All the authors revised and approved the final document for publication.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of Interest</title><p>We would like to state that Rev1&#916;<italic toggle="yes">wzm</italic> is protected by the patent WO/2019/101993 (PCT/EP2018/082539) belonging to CSIC and UPNA. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="pudiscl1"><title>Publisher&#8217;s Note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body><back><sec sec-type="funding-information" id="S8"><title>Funding</title><p>This work was funded by Agencia Estatal de Investigaci&#243;n of the Ministerio de Ciencia, Innovaci&#243;n y Universidades (AGL2014-58795-C4-2-R and RTI2018-098658-B-C21), Gobierno de Navarra (PT040-2018 and PT007-2019) projects. SM-B contracts were granted by the FEDER 2016&#8211;2018 program of Garant&#237;a Juvenil and by an UPNA pre-doctoral fellowship 2018&#8211;2022. IP-U Doctorados Industriales contract was cofounded by Gobierno de Navarra and CSIC. Research in the FC lab was supported by The Swedish Research Council (VR), The Knut and Alice Wallenberg Foundation (KAW), The Laboratory of Molecular Infection Medicine Sweden (MIMS), and The Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec><ack><p>We thank the technical support provided by Itziar Alkorta, Ricardo Andrade, and Loli Mart&#237;n (SGIker, Universidad del Pa&#237;s Vasco, Spain), the NED research group of VISAVET (Universidad Complutense de Madrid, Spain), Montse Barber&#225;n (Universidad de Zaragoza, Spain), Manuel Barr&#243;n (Laboratorio de Calidad Alimentaria de Navarra, Villava, Spain), and Goizeder Almagro (IdAB-CSIC staff). We also thank John Wild for the English revision of the manuscript.</p></ack><fn-group><fn id="footnote1"><label>1</label><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://brucellosisvaccine.org" ext-link-type="uri">https://brucellosisvaccine.org</ext-link>
</p></fn><fn id="footnote2"><label>2</label><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.gimp.org" ext-link-type="uri">www.gimp.org</ext-link>
</p></fn></fn-group><sec sec-type="supplementary-material" id="S10"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2022.908495/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2022.908495/full#supplementary-material</ext-link></p><supplementary-material id="FS1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_1.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="FS2" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_2.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_1.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS2" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_2.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS3" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_3.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS4" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_4.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS5" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_5.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS6" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_6.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="TS7" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_7.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Alton</surname><given-names>G. G.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>L.</given-names></name><name name-style="western"><surname>Angus</surname><given-names>R.</given-names></name><name name-style="western"><surname>Verger</surname><given-names>J.</given-names></name></person-group> (<year>1988</year>). <source><italic toggle="yes">Techniques for the Brucellosis Laboratory.</italic></source><publisher-loc>Paris</publisher-loc>: <publisher-name>Institut National de la Recherche Agronomique</publisher-name>.</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altschul</surname><given-names>S. F.</given-names></name><name name-style="western"><surname>Gish</surname><given-names>W.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>W.</given-names></name><name name-style="western"><surname>Myers</surname><given-names>E. W.</given-names></name><name name-style="western"><surname>Lipman</surname><given-names>D. J.</given-names></name></person-group> (<year>1990</year>). <article-title>Basic local alignment search tool.</article-title><source><italic toggle="yes">J. Mol. Biol.</italic></source><volume>215</volume><fpage>403</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cordier</surname><given-names>B.</given-names></name><name name-style="western"><surname>van Teeffelen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cava</surname><given-names>F.</given-names></name></person-group> (<year>2020</year>). <article-title>Analysis of Gram-negative bacteria peptidoglycan by ultra-performance liquid chromatography.</article-title><source><italic toggle="yes">Bio-Protocol</italic></source><volume>10</volume><fpage>1</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.21769/bioprotoc.3780</pub-id><pub-id pub-id-type="pmid">33659436</pub-id><pub-id pub-id-type="pmcid">PMC7842696</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>S. B.</given-names></name><name name-style="western"><surname>De Pedro</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Cava</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Ultra-sensitive, high-resolution liquid chromatography methods for the high-throughput quantitative analysis of bacterial cell wall chemistry and structure.</article-title><source><italic toggle="yes">Methods Mol. Biol.</italic></source><volume>1440</volume><fpage>11</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-3676-2_2</pub-id><pub-id pub-id-type="pmid">27311661</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arag&#243;n-Aranda</surname><given-names>B.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>L&#225;zaro-Ant&#243;n</surname><given-names>L.</given-names></name><name name-style="western"><surname>Salvador-Besc&#243;s</surname><given-names>M.</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic <italic toggle="yes">B. suis</italic> biovar 2 background.</article-title><source><italic toggle="yes">Vet. Res.</italic></source><volume>51</volume>:<issue>8</issue>. <pub-id pub-id-type="doi">10.1186/s13567-020-00815-8</pub-id><pub-id pub-id-type="pmid">32703299</pub-id><pub-id pub-id-type="pmcid">PMC7376850</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arellano-Reynoso</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lapaque</surname><given-names>N.</given-names></name><name name-style="western"><surname>Salcedo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Briones</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ciocchini</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Cyclic &#946;-1,2-glucan is a <italic toggle="yes">Brucella</italic> virulence factor required for intracellular survival.</article-title><source><italic toggle="yes">Nat. Immunol.</italic></source><volume>6</volume><fpage>618</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1038/ni1202</pub-id><pub-id pub-id-type="pmid">15880113</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ariza</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gudiol</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li&#241;ares</surname><given-names>J.</given-names></name><name name-style="western"><surname>Viladrich</surname><given-names>P. F.</given-names></name><name name-style="western"><surname>Mart&#237;n</surname><given-names>R.</given-names></name></person-group> (<year>1986</year>). <article-title>Relevance of <italic toggle="yes">in vitro</italic> antimicrobial susceptibility of <italic toggle="yes">Brucella melitensis</italic> to relapse rate in human brucellosis.</article-title><source><italic toggle="yes">Antimicrob. Agents Chemother.</italic></source><volume>30</volume><fpage>958</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.30.6.958</pub-id><pub-id pub-id-type="pmid">3813520</pub-id><pub-id pub-id-type="pmcid">PMC180631</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atun</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hisarli</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tun&#231;ay</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Adsorption of safranine-O on hydrophilic and hydrophobic glass surfaces.</article-title><source><italic toggle="yes">Colloids Surfaces A Physicochem. Eng. Asp.</italic></source><volume>143</volume><fpage>27</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/S0927-7757(98)00494-4</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Calder&#243;n</surname><given-names>E. D.</given-names></name><name name-style="western"><surname>Medina-Ch&#225;vez</surname><given-names>O.</given-names></name><name name-style="western"><surname>Flores-Romo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hern&#225;ndez-Hern&#225;ndez</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Donis-Maturano</surname><given-names>L.</given-names></name><name name-style="western"><surname>L&#243;pez-Merino</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Outer membrane vesicles from <italic toggle="yes">Brucella melitensis</italic> modulate immune response and induce cytoskeleton rearrangement in peripheral blood mononuclear cells.</article-title><source><italic toggle="yes">Front. Microbiol.</italic></source><volume>11</volume>:<fpage>1</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.556795</pub-id><pub-id pub-id-type="pmid">33193138</pub-id><pub-id pub-id-type="pmcid">PMC7604303</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baldwin</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Goenka</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Host immune responses to the intracellular bacteria <italic toggle="yes">Brucella</italic>: does the bacteria instruct the host to facilitate chronic infection?</article-title><source><italic toggle="yes">Crit. Rev. Immunol.</italic></source><volume>26</volume><fpage>407</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevImmunol.v26.i5.30</pub-id><pub-id pub-id-type="pmid">17341186</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrio</surname><given-names>M. B.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against <italic toggle="yes">Brucella melitensis</italic> infection of sheep.</article-title><source><italic toggle="yes">Vaccine</italic></source><volume>27</volume><fpage>1741</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.01.025</pub-id><pub-id pub-id-type="pmid">19186196</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zimmer</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Structure and ligand-binding properties of the O antigen ABC transporter carbohydrate-binding domain.</article-title><source><italic toggle="yes">Structure</italic></source><volume>28</volume><fpage>252.e</fpage>&#8211;<lpage>8.e</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2019.11.020</pub-id><pub-id pub-id-type="pmid">31879128</pub-id><pub-id pub-id-type="pmcid">PMC7004846</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mann</surname><given-names>E.</given-names></name><name name-style="western"><surname>Whitfield</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zimmer</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Architecture of a channel-forming O-antigen polysaccharide ABC transporter.</article-title><source><italic toggle="yes">Nature</italic></source><volume>553</volume><fpage>361</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/nature25190</pub-id><pub-id pub-id-type="pmid">29320481</pub-id><pub-id pub-id-type="pmcid">PMC5978415</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name></person-group> (<year>1997</year>). <article-title>A review of the use of <italic toggle="yes">B. melitensis</italic> Rev 1 vaccine in adult sheep and goats.</article-title><source><italic toggle="yes">Prev. Vet. Med.</italic></source><volume>31</volume><fpage>275</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-5877(96)01110-5</pub-id><pub-id pub-id-type="pmid">9234451</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>D&#237;az</surname><given-names>R.</given-names></name></person-group> (<year>1993</year>). <article-title><italic toggle="yes">Brucella melitensis</italic> Rev-1 vaccine as a cause of human brucellosis.</article-title><source><italic toggle="yes">Lancet</italic></source><volume>342</volume>:<issue>805</issue>. <pub-id pub-id-type="doi">10.1016/0140-6736(93)91571-3</pub-id><pub-id pub-id-type="pmid">8103891</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bosseray</surname><given-names>N.</given-names></name><name name-style="western"><surname>Plommet</surname><given-names>M.</given-names></name></person-group> (<year>1990</year>). <article-title><italic toggle="yes">Brucella suis</italic> S2, <italic toggle="yes">Brucella melitensis</italic> Rev. 1 and <italic toggle="yes">Brucella abortus</italic> S19 living vaccines: residual virulence and immunity induced against three <italic toggle="yes">Brucella</italic> species challenge strains in mice.</article-title><source><italic toggle="yes">Vaccine</italic></source><volume>8</volume><fpage>462</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(90)90247-J</pub-id><pub-id pub-id-type="pmid">2123586</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Briones</surname><given-names>G.</given-names></name><name name-style="western"><surname>I&#241;&#243;n de Iannino</surname><given-names>N.</given-names></name><name name-style="western"><surname>Roset</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vigliocco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Silva Paulo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>R. A.</given-names></name></person-group> (<year>2001</year>). <article-title><italic toggle="yes">Brucella abortus</italic> cyclic &#946;-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.</article-title><source><italic toggle="yes">Infect. Immun.</italic></source><volume>69</volume><fpage>4528</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.7.4528-4535.2001</pub-id><pub-id pub-id-type="pmid">11401996</pub-id><pub-id pub-id-type="pmcid">PMC98529</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caffalette</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Zimmer</surname><given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>Cryo-EM structure of the full-length Wzm/Wzt ABC transporter required for lipid-linked O antigen transport.</article-title><source><italic toggle="yes">Proc. Natl. Acad. Sci. U S A.</italic></source><volume>118</volume><fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2016144118</pub-id><pub-id pub-id-type="pmid">33443152</pub-id><pub-id pub-id-type="pmcid">PMC7817213</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caffalette</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Kuklewicz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Spellmon</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zimmer</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Biosynthesis and export of bacterial glycolipids.</article-title><source><italic toggle="yes">Annu. Rev. Biochem.</italic></source><volume>89</volume><fpage>741</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-011520-104707</pub-id><pub-id pub-id-type="pmid">32569526</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caro-Hern&#225;ndez</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Lago</surname><given-names>L.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Mart&#237;n-Mart&#237;n</surname><given-names>A. I.</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Role of the Omp25/Omp31 family in outer membrane properties and virulence of <italic toggle="yes">Brucella ovis</italic>.</article-title><source><italic toggle="yes">Infect. Immun.</italic></source><volume>75</volume><fpage>4050</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00486-07</pub-id><pub-id pub-id-type="pmid">17562767</pub-id><pub-id pub-id-type="pmcid">PMC1952020</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casta&#241;eda-Rold&#225;n</surname><given-names>E. I.</given-names></name><name name-style="western"><surname>Avelino-Flores</surname><given-names>F.</given-names></name><name name-style="western"><surname>Dall&#8217;Agnol</surname><given-names>M.</given-names></name><name name-style="western"><surname>Freer</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cedillo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dornand</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Adherence of <italic toggle="yes">Brucella</italic> to human epithelial cells and macrophages is mediated by sialic acid residues.</article-title><source><italic toggle="yes">Cell. Microbiol.</italic></source><volume>6</volume><fpage>435</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2004.00372.x</pub-id><pub-id pub-id-type="pmid">15056214</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheung</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shevchuk</surname><given-names>O.</given-names></name></person-group> (<year>2009</year>). <article-title>The effect of ionic (NaCl) and non-ionic (sucrose) osmotic stress on the expression of &#946;-galactosidase in wild type <italic toggle="yes">E.coli</italic> BW25993 and in the isogenic BW25993&#916;<italic toggle="yes">lacI</italic> mutant.</article-title><source><italic toggle="yes">J. Exp. Microbiol. Immunol.</italic></source><volume>13</volume><fpage>1</fpage>&#8211;<lpage>6</lpage>.</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>B. R.</given-names></name><name name-style="western"><surname>Cuthbertson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Whitfield</surname><given-names>C.</given-names></name></person-group> (<year>2004</year>). <article-title>Nonreducing terminal modifications determine the chain length of polymannose O antigens of <italic toggle="yes">Escherichia coli</italic> and couple chain termination to polymer export <italic toggle="yes">via</italic> an ATP-binding cassette transporter.</article-title><source><italic toggle="yes">J. Biol. Chem.</italic></source><volume>279</volume><fpage>35709</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M404738200</pub-id><pub-id pub-id-type="pmid">15184370</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clifton</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Ciesielski</surname><given-names>F.</given-names></name><name name-style="western"><surname>Skoda</surname><given-names>M. W. A.</given-names></name><name name-style="western"><surname>Paracini</surname><given-names>N.</given-names></name><name name-style="western"><surname>Holt</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Lakey</surname><given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>The effect of lipopolysaccharide core oligosaccharide size on the electrostatic binding of antimicrobial proteins to models of the Gram-negative bacterial outer membrane.</article-title><source><italic toggle="yes">Langmuir</italic></source><volume>32</volume><fpage>3485</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.6b00240</pub-id><pub-id pub-id-type="pmid">27003358</pub-id><pub-id pub-id-type="pmcid">PMC4854487</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V.</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M.</given-names></name><name name-style="western"><surname>Man&#269;ek-Keber</surname><given-names>M.</given-names></name><name name-style="western"><surname>Barquero-Calvo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Palacios-Chaves</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The lipopolysaccharide core of <italic toggle="yes">Brucella abortus</italic> acts as a shield against innate immunity recognition.</article-title><source><italic toggle="yes">PLoS Pathog.</italic></source><volume>8</volume>:<issue>e1002675</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002675</pub-id><pub-id pub-id-type="pmid">22589715</pub-id><pub-id pub-id-type="pmcid">PMC3349745</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuthbertson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kimber</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Whitfield</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Substrate binding by a bacterial ABC transporter involved in polysaccharide export.</article-title><source><italic toggle="yes">Proc. Natl. Acad. Sci.</italic></source><volume>104</volume><fpage>19529</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0705709104</pub-id><pub-id pub-id-type="pmid">18032609</pub-id><pub-id pub-id-type="pmcid">PMC2148323</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuthbertson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Powers</surname><given-names>J.</given-names></name><name name-style="western"><surname>Whitfield</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>The C-terminal domain of the nucleotide-binding domain protein Wzt determines substrate specificity in the ATP-binding cassette transporter for the lipopolysaccharide O-antigens in <italic toggle="yes">Escherichia coli</italic> serotypes O8 and O9a.</article-title><source><italic toggle="yes">J. Biol. Chem.</italic></source><volume>280</volume><fpage>30310</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M504371200</pub-id><pub-id pub-id-type="pmid">15980069</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Czerwonka</surname><given-names>G.</given-names></name><name name-style="western"><surname>Guzy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ka&#322;u&#380;a</surname><given-names>K.</given-names></name><name name-style="western"><surname>Grosicka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Da&#324;czuk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lechowicz</surname><given-names>&#321;</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The role of <italic toggle="yes">Proteus mirabilis</italic> cell wall features in biofilm formation.</article-title><source><italic toggle="yes">Arch. Microbiol.</italic></source><volume>198</volume><fpage>877</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/s00203-016-1249-x</pub-id><pub-id pub-id-type="pmid">27262948</pub-id><pub-id pub-id-type="pmcid">PMC5040740</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Dieste</surname><given-names>L.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Development of a selective culture medium for primary isolation of the main <italic toggle="yes">Brucella</italic> species.</article-title><source><italic toggle="yes">J. Clin. Microbiol.</italic></source><volume>49</volume><fpage>1458</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.02301-10</pub-id><pub-id pub-id-type="pmid">21270216</pub-id><pub-id pub-id-type="pmcid">PMC3122841</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Desmarais</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>De Pedro</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Cava</surname><given-names>F.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>K. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Peptidoglycan at its peaks: how chromatographic analyses can reveal bacterial cell wall structure and assembly.</article-title><source><italic toggle="yes">Mol. Microbiol.</italic></source><volume>89</volume><fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.12266</pub-id><pub-id pub-id-type="pmid">23679048</pub-id><pub-id pub-id-type="pmcid">PMC3694805</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dohnalkova</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Arey</surname><given-names>B. W.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>K. H.</given-names></name><name name-style="western"><surname>Buck</surname><given-names>E. C.</given-names></name><name name-style="western"><surname>Fredrickson</surname><given-names>J. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Imaging hydrated microbial extracellular polymers: comparative analysis by electron microscopy.</article-title><source><italic toggle="yes">Appl. Environ. Microbiol.</italic></source><volume>77</volume><fpage>1254</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02001-10</pub-id><pub-id pub-id-type="pmid">21169451</pub-id><pub-id pub-id-type="pmcid">PMC3067245</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name></person-group> (<year>2015</year>). <article-title>The effects of RegM on stress responses in <italic toggle="yes">Brucella melitensis</italic>.</article-title><source><italic toggle="yes">Curr. Microbiol.</italic></source><volume>70</volume><fpage>730</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-015-0782-1</pub-id><pub-id pub-id-type="pmid">25648428</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorneles</surname><given-names>E. M. S.</given-names></name><name name-style="western"><surname>Teixeira-Carvalho</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ara&#250;jo</surname><given-names>M. S. S.</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lage</surname><given-names>A. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Immune response triggered by <italic toggle="yes">Brucella abortus</italic> following infection or vaccination.</article-title><source><italic toggle="yes">Vaccine</italic></source><volume>33</volume><fpage>3659</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.05.057</pub-id><pub-id pub-id-type="pmid">26048781</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="book"><collab>EUCAST: European Committee for Antimicrobial Susceptibility Testing.</collab> (<year>2003</year>). <source><italic toggle="yes">Determination of Minimum Inhibitory Concentrations (MICs) of Antibacterial Agents by Broth Dilution.</italic></source><publisher-loc>Central Hospital V&#228;xj&#246;</publisher-loc>: <publisher-name>EUCAST</publisher-name>.</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fletcher</surname><given-names>M.</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>G. I.</given-names></name></person-group> (<year>1979</year>). <article-title>Influence of substratum characteristics on the attachment of a marine <italic toggle="yes">Pseudomonas</italic> to solid surfaces.</article-title><source><italic toggle="yes">Appl. Environ. Microbiol.</italic></source><volume>37</volume><fpage>67</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1128/aem.37.1.67-72.1979</pub-id><pub-id pub-id-type="pmid">16345338</pub-id><pub-id pub-id-type="pmcid">PMC243402</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontana</surname><given-names>C.</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R.</given-names></name><name name-style="western"><surname>St&#229;hle</surname><given-names>J.</given-names></name><name name-style="western"><surname>Holst</surname><given-names>O.</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Structural studies of lipopolysaccharide-defective mutants from <italic toggle="yes">Brucella melitensis</italic> identify a core oligosaccharide critical in virulence.</article-title><source><italic toggle="yes">J. Biol. Chem.</italic></source><volume>291</volume><fpage>7727</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.701540</pub-id><pub-id pub-id-type="pmid">26867577</pub-id><pub-id pub-id-type="pmcid">PMC4817197</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gamazo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I.</given-names></name></person-group> (<year>1987</year>). <article-title>Release of outer membrane fragments by exponentially growing <italic toggle="yes">Brucella melitensis</italic> cells.</article-title><source><italic toggle="yes">Infect. Immun.</italic></source><volume>55</volume><fpage>609</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1128/iai.55.3.609-615.1987</pub-id><pub-id pub-id-type="pmid">3818086</pub-id><pub-id pub-id-type="pmcid">PMC260382</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godefroid</surname><given-names>M.</given-names></name><name name-style="western"><surname>Svensson</surname><given-names>M. V.</given-names></name><name name-style="western"><surname>Cambier</surname><given-names>P.</given-names></name><name name-style="western"><surname>Uzureau</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mirabella</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Bolle</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title><italic toggle="yes">Brucella melitensis</italic> 16M produces a mannan and other extracellular matrix components typical of a biofilm.</article-title><source><italic toggle="yes">FEMS Immunol. Med. Microbiol.</italic></source><volume>59</volume><fpage>364</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-695X.2010.00689.x</pub-id><pub-id pub-id-type="pmid">20497223</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godessart</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lannoy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dieu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Van der Verren</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Soumillion</surname><given-names>P.</given-names></name><name name-style="western"><surname>Collet</surname><given-names>J. F.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>&#946;-barrels covalently link peptidoglycan and the outer membrane in the &#945;-proteobacterium <italic toggle="yes">Brucella abortus</italic>.</article-title><source><italic toggle="yes">Nat. Microbiol.</italic></source><volume>6</volume><fpage>27</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-020-00799-3</pub-id><pub-id pub-id-type="pmid">33139884</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godfroid</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A.</given-names></name><name name-style="western"><surname>Taminiau</surname><given-names>B.</given-names></name><name name-style="western"><surname>Danese</surname><given-names>I.</given-names></name><name name-style="western"><surname>Tibor</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Bolle</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of <italic toggle="yes">Brucella melitensis</italic> 16M (<italic toggle="yes">wbk</italic>).</article-title><source><italic toggle="yes">Res. Microbiol.</italic></source><volume>151</volume><fpage>655</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/s0923-2508(00)90130-x</pub-id><pub-id pub-id-type="pmid">11081580</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>J. B.</given-names></name></person-group> (<year>1999</year>). <source><italic toggle="yes">Genetics of Bacterial Polysaccharides</italic></source>, <edition>1st Edn</edition>. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press LLC</publisher-name>, <pub-id pub-id-type="doi">10.1201/9781420074413</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>T.</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V.</given-names></name><name name-style="western"><surname>Delrue</surname><given-names>R. M.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Brucellosis vaccines: assessment of <italic toggle="yes">Brucella melitensis</italic> lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export.</article-title><source><italic toggle="yes">PLoS One</italic></source><volume>3</volume>:<issue>e2760</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0002760</pub-id><pub-id pub-id-type="pmid">18648644</pub-id><pub-id pub-id-type="pmcid">PMC2453230</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I.</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>What have we learned from brucellosis in the mouse model?</article-title><source><italic toggle="yes">Vet. Res.</italic></source><volume>43</volume><fpage>1</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1186/1297-9716-43-29</pub-id><pub-id pub-id-type="pmid">22500859</pub-id><pub-id pub-id-type="pmcid">PMC3410789</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Bosseray</surname><given-names>N.</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>). <article-title><italic toggle="yes">In vitro</italic> markers and biological activity in mice of seed lot strains and commercial <italic toggle="yes">Brucella melitensis</italic> Rev 1 and <italic toggle="yes">Brucella abortus</italic> B19 vaccines.</article-title><source><italic toggle="yes">Biologicals</italic></source><volume>28</volume><fpage>119</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1006/biol.2000.0249</pub-id><pub-id pub-id-type="pmid">10885618</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Manterola</surname><given-names>L.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2006b</year>). <article-title>Increases of efficacy as vaccine against <italic toggle="yes">Brucella abortus</italic> infection in mice by simultaneous inoculation with avirulent smooth <italic toggle="yes">bvrS</italic>/<italic toggle="yes">bvrR</italic> and rough <italic toggle="yes">wbkA</italic> mutants.</article-title><source><italic toggle="yes">Vaccine</italic></source><volume>24</volume><fpage>2910</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2005.12.038</pub-id><pub-id pub-id-type="pmid">16439039</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Ariza</surname><given-names>J.</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name></person-group> (<year>2006a</year>). <article-title>Efficacy of several antibiotic combinations against <italic toggle="yes">Brucella melitensis</italic> Rev 1 experimental infection in BALB/c mice.</article-title><source><italic toggle="yes">J. Antimicrob. Chemother.</italic></source><volume>58</volume><fpage>622</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkl289</pub-id><pub-id pub-id-type="pmid">16849379</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>San Rom&#225;n Aberasturi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Palacios Chaves</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mena Bueno</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zabalza Barangu&#225;</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <source><italic toggle="yes">A Modified Brucella Vaccine Strain for the Treatment of Brucellosis.</italic></source><publisher-loc>Madrid</publisher-loc>: <publisher-name>Consejo Superior de Investigaciones Cient&#237;ficas</publisher-name>.</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guidolin</surname><given-names>L. S.</given-names></name><name name-style="western"><surname>Morrone Seijo</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Guaimas</surname><given-names>F. F.</given-names></name><name name-style="western"><surname>Comerci</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Ciocchinia</surname><given-names>A. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Interaction network and localization of <italic toggle="yes">Brucella abortus</italic> membrane proteins involved in the synthesis, transport, and succinylation of cyclic &#946;-1,2-glucans.</article-title><source><italic toggle="yes">J. Bacteriol.</italic></source><volume>197</volume><fpage>1640</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00068-15</pub-id><pub-id pub-id-type="pmid">25733613</pub-id><pub-id pub-id-type="pmcid">PMC4403662</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Geng</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Safety, protective immunity, and DIVA capability of a rough mutant <italic toggle="yes">Salmonella</italic> Pullorum vaccine candidate in broilers.</article-title><source><italic toggle="yes">Front. Microbiol.</italic></source><volume>8</volume>:<fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.00547</pub-id><pub-id pub-id-type="pmid">28424675</pub-id><pub-id pub-id-type="pmcid">PMC5380749</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haag</surname><given-names>A. F.</given-names></name><name name-style="western"><surname>Myka</surname><given-names>K. K.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>M. F. F.</given-names></name><name name-style="western"><surname>Caro-Hern&#225;ndez</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>G. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Importance of lipopolysaccharide and cyclic &#946;-1,2-glucans in <italic toggle="yes">Brucella</italic>-mammalian infections.</article-title><source><italic toggle="yes">Int. J. Microbiol.</italic></source><volume>2010</volume><fpage>1</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1155/2010/124509</pub-id><pub-id pub-id-type="pmid">21151694</pub-id><pub-id pub-id-type="pmcid">PMC2995898</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagelueken</surname><given-names>G.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>B. R.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tuukkanen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Danciu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Svergun</surname><given-names>D. I.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>A coiled-coil domain acts as a molecular ruler to regulate O-antigen chain length in lipopolysaccharide.</article-title><source><italic toggle="yes">Nat. Struct. Mol. Biol.</italic></source><volume>22</volume><fpage>50</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2935</pub-id><pub-id pub-id-type="pmid">25504321</pub-id><pub-id pub-id-type="pmcid">PMC4650267</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hensel</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Garcia-Gonzalez</surname><given-names>D. G.</given-names></name><name name-style="western"><surname>Chaki</surname><given-names>S. P.</given-names></name><name name-style="western"><surname>Hartwig</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gordy</surname><given-names>P. W.</given-names></name><name name-style="western"><surname>Bowen</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Vaccine candidate <italic toggle="yes">Brucella melitensis</italic> 16M&#916;<italic toggle="yes">vjbR</italic> is safe in a pregnant sheep model and confers protection.</article-title><source><italic toggle="yes">mSphere</italic></source><volume>5</volume>:<issue>20</issue>. <pub-id pub-id-type="doi">10.1128/msphere.00120-20</pub-id><pub-id pub-id-type="pmid">32404509</pub-id><pub-id pub-id-type="pmcid">PMC7227765</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hug</surname><given-names>I.</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>M. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Analogies and homologies in lipopolysaccharide and glycoprotein biosynthesis in bacteria.</article-title><source><italic toggle="yes">Glycobiology</italic></source><volume>21</volume><fpage>138</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwq148</pub-id><pub-id pub-id-type="pmid">20871101</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Issa</surname><given-names>M. N.</given-names></name><name name-style="western"><surname>Ashhab</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Identification of <italic toggle="yes">Brucella melitensis</italic> Rev.1 vaccine-strain genetic markers: towards understanding the molecular mechanism behind virulence attenuation.</article-title><source><italic toggle="yes">Vaccine</italic></source><volume>34</volume><fpage>4884</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.08.059</pub-id><pub-id pub-id-type="pmid">27595444</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izquierdo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Merino</surname><given-names>S.</given-names></name><name name-style="western"><surname>Regu&#233;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tom&#225;s</surname><given-names>J. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Synthesis of a <italic toggle="yes">Klebsiella pneumoniae</italic> O-antigen heteropolysaccharide (O12) requires an ABC 2 transporter.</article-title><source><italic toggle="yes">J. Bacteriol.</italic></source><volume>185</volume><fpage>1634</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1128/JB.185.5.1634-1641.2003</pub-id><pub-id pub-id-type="pmid">12591881</pub-id><pub-id pub-id-type="pmcid">PMC148082</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain-Gupta</surname><given-names>N.</given-names></name><name name-style="western"><surname>Waldrop</surname><given-names>S. G.</given-names></name><name name-style="western"><surname>Tenpenny</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Witonsky</surname><given-names>S. G.</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N.</given-names></name></person-group> (<year>2019</year>). <article-title>Rough <italic toggle="yes">Brucella neotomae</italic> provides protection against <italic toggle="yes">Brucella suis</italic> challenge in mice.</article-title><source><italic toggle="yes">Vet. Microbiol.</italic></source><volume>239</volume>:<issue>108447</issue>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2019.108447</pub-id><pub-id pub-id-type="pmid">31767087</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jankowski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jankowski</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miro&#324;czyk</surname><given-names>A.</given-names></name><name name-style="western"><surname>Niedbach</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The action of photosensitizers and serum in a bactericidal process. II. The effects of dyes: hypericin, eosin Y and saphranine O.</article-title><source><italic toggle="yes">Polish J. Microbiol.</italic></source><volume>54</volume><fpage>323</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="pmid">16599305</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jim&#233;nez de Bag&#252;&#233;s</surname><given-names>M. P.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Barber&#225;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>J. M.</given-names></name></person-group> (<year>1989</year>). <article-title>Responses of ewes to <italic toggle="yes">B. melitensis</italic> Rev1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy.</article-title><source><italic toggle="yes">Ann. Rech. Vet.</italic></source><volume>20</volume><fpage>205</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="pmid">2751232</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>Z. I.</given-names></name><name name-style="western"><surname>Chisholm</surname><given-names>S. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Properties of overlapping genes are conserved across microbial genomes.</article-title><source><italic toggle="yes">Genome Res.</italic></source><volume>14</volume><fpage>2268</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1101/gr.2433104</pub-id><pub-id pub-id-type="pmid">15520290</pub-id><pub-id pub-id-type="pmcid">PMC525685</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamens</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>The Addgene repository: an international nonprofit plasmid and data resource.</article-title><source><italic toggle="yes">Nucleic Acids Res.</italic></source><volume>43</volume><fpage>D1152</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku893</pub-id><pub-id pub-id-type="pmid">25392412</pub-id><pub-id pub-id-type="pmcid">PMC4384007</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanehisa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Goto</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>KEGG: kyoto encyclopedia of genes and genomes.</article-title><source><italic toggle="yes">Nucleic Acids Res.</italic></source><volume>28</volume><fpage>27</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><pub-id pub-id-type="pmid">10592173</pub-id><pub-id pub-id-type="pmcid">PMC102409</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohanski</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Dwyer</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>J. J.</given-names></name></person-group> (<year>2010</year>). <article-title>How antibiotics kill bacteria: from targets to networks.</article-title><source><italic toggle="yes">Nat. Rev. Microbiol.</italic></source><volume>8</volume><fpage>423</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2333</pub-id><pub-id pub-id-type="pmid">20440275</pub-id><pub-id pub-id-type="pmcid">PMC2896384</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kornspan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lubkovskaia</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mathur</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yeheskel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Salmon-Divon</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Genomic analysis of natural rough <italic toggle="yes">Brucella melitensis</italic> Rev.1 vaccine strains: identification and characterization of mutations in key genes associated with bacterial lps biosynthesis and virulence.</article-title><source><italic toggle="yes">Int. J. Mol. Sci.</italic></source><volume>21</volume><fpage>1</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3390/ijms21249341</pub-id><pub-id pub-id-type="pmid">33302421</pub-id><pub-id pub-id-type="pmcid">PMC7762576</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreutzer</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Scheffel</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Draper</surname><given-names>L. R.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>D. C.</given-names></name></person-group> (<year>1977</year>). <article-title>Mitogenic activity of cell wall components from smooth and rough strains of <italic toggle="yes">Brucella abortus</italic>.</article-title><source><italic toggle="yes">Infect. Immun.</italic></source><volume>15</volume><fpage>842</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1128/iai.15.3.842-845.1977</pub-id><pub-id pub-id-type="pmid">404248</pub-id><pub-id pub-id-type="pmcid">PMC421449</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kuo</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <source><italic toggle="yes">Electron Microscopy: Methods and Protocols</italic></source>, <edition>2nd Edn</edition>. <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press Inc</publisher-name>, <pub-id pub-id-type="doi">10.1007/978-1-62703-776-1</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalsiamthara</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gogia</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Goswami</surname><given-names>T. K.</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title><italic toggle="yes">Brucella abortus</italic> S19 <italic toggle="yes">rfbD</italic> mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice.</article-title><source><italic toggle="yes">Biologicals</italic></source><volume>63</volume><fpage>62</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.biologicals.2019.11.005</pub-id><pub-id pub-id-type="pmid">31843357</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lepage</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lakaye</surname><given-names>B.</given-names></name><name name-style="western"><surname>Galleni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Thamm</surname><given-names>I.</given-names></name><name name-style="western"><surname>Crine</surname><given-names>M.</given-names></name><name name-style="western"><surname>Groslambert</surname><given-names>S.</given-names></name><etal/></person-group> (<year>1995</year>). <article-title>Saturation of penicillin-binding protein 1 by &#946;&#8722;lactam antibiotics in growing cells of <italic toggle="yes">Bacillus licheniformis</italic>.</article-title><source><italic toggle="yes">Mol. Microbiol.</italic></source><volume>16</volume><fpage>365</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1995.tb02308.x</pub-id><pub-id pub-id-type="pmid">7565098</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lerouge</surname><given-names>I.</given-names></name><name name-style="western"><surname>Laeremans</surname><given-names>T.</given-names></name><name name-style="western"><surname>Verreth</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vanderleyden</surname><given-names>J.</given-names></name><name name-style="western"><surname>Van Soom</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tobin</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Identification of an ATP-binding cassette transporter for export of the O-antigen across the inner membrane in <italic toggle="yes">Rhizobium etli</italic> based on the genetic, functional, and structural analysis of an LPS mutant deficient in O-antigen.</article-title><source><italic toggle="yes">J. Biol. Chem.</italic></source><volume>276</volume><fpage>17190</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M101129200</pub-id><pub-id pub-id-type="pmid">11279176</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Livermore</surname><given-names>D. M.</given-names></name></person-group> (<year>1987</year>). <article-title>Mechanisms of resistance to cephalosporin antibiotics.</article-title><source><italic toggle="yes">Drugs</italic></source><volume>34</volume><fpage>64</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.2165/00003495-198700342-00007</pub-id><pub-id pub-id-type="pmid">3319506</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mancilla</surname><given-names>M.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I.</given-names></name><name name-style="western"><surname>San-Rom&#225;n</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zabalza-Barangu&#225;</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Deletion of the GI-2 integrase and the <italic toggle="yes">wbkA</italic> flanking transposase improves the stability of <italic toggle="yes">Brucella melitensis</italic> Rev 1 vaccine.</article-title><source><italic toggle="yes">Vet. Res.</italic></source><volume>44</volume><fpage>1</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1186/1297-9716-44-105</pub-id><pub-id pub-id-type="pmid">24176078</pub-id><pub-id pub-id-type="pmcid">PMC4176087</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez de Tejada</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pizarro-Cerd&#225;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E.</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I.</given-names></name></person-group> (<year>1995</year>). <article-title>The outer membranes of <italic toggle="yes">Brucella</italic> spp. are resistant to bactericidal cationic peptides.</article-title><source><italic toggle="yes">Infect. Immun.</italic></source><volume>63</volume><fpage>3054</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1128/iai.63.8.3054-3061</pub-id><pub-id pub-id-type="pmid">7622230</pub-id><pub-id pub-id-type="pmcid">PMC173416</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirabella</surname><given-names>A.</given-names></name><name name-style="western"><surname>Terwagne</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Bolle</surname><given-names>X.</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>J. J.</given-names></name></person-group> (<year>2013</year>). <article-title><italic toggle="yes">Brucella melitensis</italic> MucR, an orthologue of <italic toggle="yes">Sinorhizobium meliloti</italic> MucR, is involved in resistance to oxidative, detergent, and saline stresses and cell envelope modifications.</article-title><source><italic toggle="yes">J. Bacteriol.</italic></source><volume>195</volume><fpage>453</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01336-12</pub-id><pub-id pub-id-type="pmid">23161025</pub-id><pub-id pub-id-type="pmcid">PMC3554010</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammad</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Tomita</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Movileanu</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>The transmembrane domain of a bicomponent ABC transporter exhibits channel-forming activity.</article-title><source><italic toggle="yes">ACS Chem. Biol.</italic></source><volume>11</volume><fpage>2506</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.6b00383</pub-id><pub-id pub-id-type="pmid">27379442</pub-id><pub-id pub-id-type="pmcid">PMC5026576</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monreal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>De Miguel</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Characterization of <italic toggle="yes">Brucella abortus</italic> O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against <italic toggle="yes">Brucella abortus</italic> and <italic toggle="yes">Brucella ovis</italic> in the mouse model.</article-title><source><italic toggle="yes">Infect. Immun.</italic></source><volume>71</volume><fpage>3261</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.6.3261-3271.2003</pub-id><pub-id pub-id-type="pmid">12761107</pub-id><pub-id pub-id-type="pmcid">PMC155776</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montaraz</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Winter</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Sowa</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>L. G.</given-names></name></person-group> (<year>1986</year>). <article-title>Protection against <italic toggle="yes">Brucella abortus</italic> in mice with O-polysaccharide-specific monoclonal antibodies.</article-title><source><italic toggle="yes">Infect. Immun.</italic></source><volume>51</volume><fpage>961</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1128/iai.51.3.961-963.1986</pub-id><pub-id pub-id-type="pmid">3005173</pub-id><pub-id pub-id-type="pmcid">PMC260994</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moosavian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Emam</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pletzer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Savari</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Rough-type and loss of the LPS due to <italic toggle="yes">lpx</italic> genes deletions are associated with colistin resistance in multidrug-resistant clinical <italic toggle="yes">Escherichia coli</italic> isolates not harbouring <italic toggle="yes">mcr</italic> genes.</article-title><source><italic toggle="yes">PLoS One</italic></source><volume>15</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0233518</pub-id><pub-id pub-id-type="pmid">32433662</pub-id><pub-id pub-id-type="pmcid">PMC7239443</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mor&#232;</surname><given-names>N.</given-names></name><name name-style="western"><surname>Martorana</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Biboy</surname><given-names>J.</given-names></name><name name-style="western"><surname>Otten</surname><given-names>C.</given-names></name><name name-style="western"><surname>Winkle</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gurnani Serrano</surname><given-names>C. K.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Peptidoglycan remodeling enables <italic toggle="yes">Escherichia coli</italic> to survive severe outer membrane assembly defect.</article-title><source><italic toggle="yes">MBio</italic></source><volume>10</volume><fpage>e2729</fpage>&#8211;<lpage>2718</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mBio.02729-18</pub-id><pub-id pub-id-type="pmcid">PMC6428754</pub-id><pub-id pub-id-type="pmid">30723128</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Monreal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mar&#237;n</surname><given-names>C.</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Rough vaccines in animal brucellosis: structural and genetic basis and present status.</article-title><source><italic toggle="yes">Vet. Res.</italic></source><volume>35</volume><fpage>1</fpage>&#8211;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1051/vetres:2003037</pub-id><pub-id pub-id-type="pmid">15099501</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakao</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ramstedt</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wai</surname><given-names>S. N.</given-names></name><name name-style="western"><surname>Uhlin</surname><given-names>B. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Enhanced biofilm formation by <italic toggle="yes">Escherichia coli</italic> LPS mutants defective in Hep biosynthesis.</article-title><source><italic toggle="yes">PLoS One</italic></source><volume>7</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0051241</pub-id><pub-id pub-id-type="pmid">23284671</pub-id><pub-id pub-id-type="pmcid">PMC3532297</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikaido</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vaara</surname><given-names>M.</given-names></name></person-group> (<year>1985</year>). <article-title>Molecular basis of bacterial outer membrane permeability.</article-title><source><italic toggle="yes">N Y. State J. Med.</italic></source><volume>49</volume><fpage>1</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1128/mr.49.1.1-32.1985</pub-id><pub-id pub-id-type="pmid">2580220</pub-id><pub-id pub-id-type="pmcid">PMC373015</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="book"><collab>OIE</collab> (<year>2018</year>). &#8220;<article-title>Chapter 3.1.4: Brucellosis (<italic toggle="yes">Brucella abortus</italic>, <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. suis</italic>) (Infection with <italic toggle="yes">B. abortus</italic>, <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. suis</italic>)&#8217;</article-title>,&#8221; in <source><italic toggle="yes">Office International of Epizooties, World Organisation for Animal Health. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.</italic></source> (<publisher-loc>Paris</publisher-loc>: <publisher-name>World Organisation for Animal Health</publisher-name>).</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Percie du Sert</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hurst</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ahluwalia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Avey</surname><given-names>M. T.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>The ARRIVE guidelines 2.0: updated guidelines for reporting animal research.</article-title><source><italic toggle="yes">PLoS Biol.</italic></source><volume>18</volume>:<issue>e3000410</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3000410</pub-id><pub-id pub-id-type="pmid">32663219</pub-id><pub-id pub-id-type="pmcid">PMC7360023</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perevoshchikova</surname><given-names>I. V.</given-names></name><name name-style="western"><surname>Sorochkina</surname><given-names>A. I.</given-names></name><name name-style="western"><surname>Zorov</surname><given-names>D. B.</given-names></name><name name-style="western"><surname>Antonenko</surname><given-names>Y. N.</given-names></name></person-group> (<year>2009</year>). <article-title>Safranine O as a fluorescent probe for mitochondrial membrane potential studied on the single particle level and in suspension.</article-title><source><italic toggle="yes">Biochem</italic></source><volume>74</volume><fpage>663</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1134/s000629790906011x</pub-id><pub-id pub-id-type="pmid">19645672</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-Sancho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garc&#237;a-Seco</surname><given-names>T.</given-names></name><name name-style="western"><surname>Arrogante</surname><given-names>L.</given-names></name><name name-style="western"><surname>Garc&#237;a</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>I.</given-names></name><name name-style="western"><surname>Diez-Guerrier</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Development and evaluation of an IS<italic toggle="yes">711</italic>-based loop mediated isothermal amplification method (LAMP) for detection of <italic toggle="yes">Brucella</italic> spp. on clinical samples.</article-title><source><italic toggle="yes">Res. Vet. Sci.</italic></source><volume>95</volume><fpage>489</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.rvsc.2013.05.002</pub-id><pub-id pub-id-type="pmid">23714043</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pazos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Edoo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Hugonnet</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Martorana</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Polissi</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Copper inhibits peptidoglycan LD-transpeptidases suppressing &#946;-lactam resistance due to bypass of penicillin-binding proteins.</article-title><source><italic toggle="yes">Proc. Natl. Acad. Sci. U S A.</italic></source><volume>115</volume><fpage>10786</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1809285115</pub-id><pub-id pub-id-type="pmid">30275297</pub-id><pub-id pub-id-type="pmcid">PMC6196517</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pilizota</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shaevitz</surname><given-names>J. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Plasmolysis and cell shape depend on solute outer-membrane permeability during hyperosmotic shock in <italic toggle="yes">E. coli</italic>.</article-title><source><italic toggle="yes">Biophys. J.</italic></source><volume>104</volume><fpage>2733</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2013.05.011</pub-id><pub-id pub-id-type="pmid">23790382</pub-id><pub-id pub-id-type="pmcid">PMC3686340</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Popescu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Doyle</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>The Gram stain after more than a century.</article-title><source><italic toggle="yes">Biotech. Histochem.</italic></source><volume>71</volume><fpage>145</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/S0246-0343(10)19912-2</pub-id><pub-id pub-id-type="pmid">8724440</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poveda-Urkixo</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ram&#237;rez</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Grill&#243;</surname><given-names>M.-J.</given-names></name></person-group> (<year>2022</year>). <article-title>Kinetics of placental infection by different smooth <italic toggle="yes">Brucella</italic> strains in mice.</article-title><source><italic toggle="yes">Pathogens</italic></source><volume>11</volume><fpage>1</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.3390/PATHOGENS11030279</pub-id><pub-id pub-id-type="pmid">35335603</pub-id><pub-id pub-id-type="pmcid">PMC8955611</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quandt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hynes</surname><given-names>M. F.</given-names></name></person-group> (<year>1993</year>). <article-title>Versatile suicide vectors which allow direct selection for gene replacement in Gram-negative bacteria.</article-title><source><italic toggle="yes">Gene</italic></source><volume>127</volume><fpage>15</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(93)90611-6</pub-id><pub-id pub-id-type="pmid">8486283</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rehbinder</surname><given-names>C.</given-names></name><name name-style="western"><surname>Alenius</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bures</surname><given-names>J.</given-names></name><name name-style="western"><surname>De las Heras</surname><given-names>M.</given-names></name><name name-style="western"><surname>Greko</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kroon</surname><given-names>P. S.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>FELASA recommendations for the health monitoring of experimental units of calves, sheep and goats - Report of the federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health.</article-title><source><italic toggle="yes">Lab. Anim.</italic></source><volume>34</volume><fpage>329</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1258/002367700780387723</pub-id><pub-id pub-id-type="pmid">11072854</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rocchetta</surname><given-names>H. L.</given-names></name><name name-style="western"><surname>Lam</surname><given-names>J. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Identification and functional characterization of an ABC transport system involved in polysaccharide export of A-band lipopolysaccharide in <italic toggle="yes">Pseudomonas aeruginosa</italic>.</article-title><source><italic toggle="yes">J. Bacteriol.</italic></source><volume>179</volume><fpage>4713</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1128/jb.179.15.4713-4724.1997</pub-id><pub-id pub-id-type="pmid">9244257</pub-id><pub-id pub-id-type="pmcid">PMC179316</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gutnick</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>E.</given-names></name></person-group> (<year>1980</year>). <article-title>Adherence of bacteria to hydrocarbons: a simple method for measuring cell-surface hydrophobicity.</article-title><source><italic toggle="yes">FEMS Microbiol. Lett.</italic></source><volume>9</volume><fpage>29</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1980.tb05599.x</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roset</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Ciocchini</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>I&#241;&#243;n de Iannino</surname><given-names>N.</given-names></name></person-group> (<year>2006</year>). <article-title>The <italic toggle="yes">Brucella abortus</italic>cyclic &#946;-1,2-glucan virulence factor is substituted with O-ester-linked succinyl residues.</article-title><source><italic toggle="yes">J. Bacteriol.</italic></source><volume>188</volume><fpage>5003</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00086-06</pub-id><pub-id pub-id-type="pmid">16816173</pub-id><pub-id pub-id-type="pmcid">PMC1539967</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roset</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Iba&#241;ez</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>De Souza Filho</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Spera</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Minatel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>S. C.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title><italic toggle="yes">Brucella</italic> cyclic B-1,2-glucan plays a critical role in the induction of splenomegaly in mice.</article-title><source><italic toggle="yes">PLoS One</italic></source><volume>9</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0101279</pub-id><pub-id pub-id-type="pmid">24983999</pub-id><pub-id pub-id-type="pmcid">PMC4077732</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruiz-Palma</surname><given-names>M.</given-names></name><name name-style="western"><surname>del</surname><given-names>S.</given-names></name><name name-style="western"><surname>Avila-Calder&#243;n</surname><given-names>E. D.</given-names></name><name name-style="western"><surname>Aguilera-Arreola</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>L&#243;pez-Merino</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>E. A.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Comparative proteomic analysis of outer membrane vesicles from <italic toggle="yes">Brucella suis</italic>, <italic toggle="yes">Brucella ovis</italic>, <italic toggle="yes">Brucella canis</italic> and <italic toggle="yes">Brucella neotomae</italic>.</article-title><source><italic toggle="yes">Arch. Microbiol.</italic></source><volume>203</volume><fpage>1611</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s00203-020-02170-w</pub-id><pub-id pub-id-type="pmid">33432377</pub-id><pub-id pub-id-type="pmcid">PMC7799404</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salcedo</surname><given-names>S. P.</given-names></name><name name-style="western"><surname>Chevrier</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lacerda</surname><given-names>T. L. S.</given-names></name><name name-style="western"><surname>Ben Amara</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gerart</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>V. A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Pathogenic brucellae replicate in human trophoblasts.</article-title><source><italic toggle="yes">J. Infect. Dis.</italic></source><volume>207</volume><fpage>1075</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jit007</pub-id><pub-id pub-id-type="pmid">23303808</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmon-Divon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yeheskel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kornspan</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Genomic analysis of the original Elberg <italic toggle="yes">Brucella melitensis</italic> Rev.1 vaccine strain reveals insights into virulence attenuation.</article-title><source><italic toggle="yes">Lab. Anim.</italic></source><volume>9</volume><fpage>1436</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2018.1511677</pub-id><pub-id pub-id-type="pmid">30139304</pub-id><pub-id pub-id-type="pmcid">PMC6141144</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmon-Divon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zahavi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kornspan</surname><given-names>D.</given-names></name></person-group> (<year>2019</year>). <article-title>Transcriptomic analysis of the <italic toggle="yes">Brucella melitensis</italic> Rev.1 vaccine strain in an acidic environment: insights into virulence attenuation.</article-title><source><italic toggle="yes">Front. Microbiol.</italic></source><volume>10</volume>:<fpage>1</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.00250</pub-id><pub-id pub-id-type="pmid">30837973</pub-id><pub-id pub-id-type="pmcid">PMC6382750</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sancho</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tejedor</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sidhu-Mu&#241;oz</surname><given-names>R. S.</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Lago</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vizca&#237;no</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Evaluation in mice of <italic toggle="yes">Brucella ovis</italic> attenuated mutants for use as live vaccines against <italic toggle="yes">B. ovis</italic> infection.</article-title><source><italic toggle="yes">Vet. Res.</italic></source><volume>45</volume><fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1186/1297-9716-45-61</pub-id><pub-id pub-id-type="pmid">24898325</pub-id><pub-id pub-id-type="pmcid">PMC4057616</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sayers</surname><given-names>E. W.</given-names></name><name name-style="western"><surname>Bolton</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Brister</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Canese</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Comeau</surname><given-names>D. C.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Database resources of the National Center for Biotechnology Information (NCBI).</article-title><source><italic toggle="yes">Nucleic Acids Res.</italic></source><volume>50</volume><fpage>D20</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab1112</pub-id><pub-id pub-id-type="pmid">34850941</pub-id><pub-id pub-id-type="pmcid">PMC8728269</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schindelin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Arganda-Carreras</surname><given-names>I.</given-names></name><name name-style="western"><surname>Frise</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kaynig</surname><given-names>V.</given-names></name><name name-style="western"><surname>Longair</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pietzsch</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Fiji: an open-source platform for biological-image analysis.</article-title><source><italic toggle="yes">Nat. Methods</italic></source><volume>9</volume><fpage>676</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id><pub-id pub-id-type="pmcid">PMC3855844</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schurig</surname><given-names>G. G.</given-names></name><name name-style="western"><surname>Roop</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Bagchi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>S.</given-names></name><name name-style="western"><surname>Buhrman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N.</given-names></name></person-group> (<year>1991</year>). <article-title>Biological properties of RB51; a stable rough strain of <italic toggle="yes">Brucella abortus</italic>.</article-title><source><italic toggle="yes">Vet. Microbiol.</italic></source><volume>28</volume><fpage>171</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1135(91)90091-S</pub-id><pub-id pub-id-type="pmid">1908158</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schurig</surname><given-names>G. G.</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Corbel</surname><given-names>M. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Brucellosis vaccines: past, present and future.</article-title><source><italic toggle="yes">Vet. Microbiol.</italic></source><volume>90</volume><fpage>479</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00255-9</pub-id><pub-id pub-id-type="pmid">12414166</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuster</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>Wiedemann</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Kirsebom</surname><given-names>F. C. M.</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>M.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gr&#252;ndling</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>High-throughput transposon sequencing highlights the cell wall as an important barrier for osmotic stress in methicillin resistant <italic toggle="yes">Staphylococcus aureus</italic> and underlines a tailored response to different osmotic stressors.</article-title><source><italic toggle="yes">Mol. Microbiol.</italic></source><volume>113</volume><fpage>699</fpage>&#8211;<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.14433</pub-id><pub-id pub-id-type="pmid">31770461</pub-id><pub-id pub-id-type="pmcid">PMC7176532</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scupham</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Triplett</surname><given-names>E. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Isolation and characterization of the UDP-glucose 4&#8217;-epimerase-encoding gene, <italic toggle="yes">galE</italic>, from <italic toggle="yes">Brucella abortus</italic> 2308.</article-title><source><italic toggle="yes">Gene</italic></source><volume>202</volume><fpage>53</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/s0378-1119(97)00453-8</pub-id><pub-id pub-id-type="pmid">9427545</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shabala</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ross</surname><given-names>T.</given-names></name><name name-style="western"><surname>McMeekin</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shabala</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Ion transport and osmotic adjustment in <italic toggle="yes">Escherichia coli</italic> in response to ionic and non-ionic osmotica.</article-title><source><italic toggle="yes">Environ. Microbiol.</italic></source><volume>11</volume><fpage>137</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-2920.2008.01748.x</pub-id><pub-id pub-id-type="pmid">18793315</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>D. R.</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Patowary</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stoneman</surname><given-names>M. R.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Movileanu</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Determination of the quaternary structure of a bacterial ATP-binding cassette (ABC) transporter in living cells.</article-title><source><italic toggle="yes">Integr. Biol.</italic></source><volume>5</volume><fpage>312</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1039/C2IB20218B</pub-id><pub-id pub-id-type="pmid">23223798</pub-id><pub-id pub-id-type="pmcid">PMC3558595</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gangadharan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Weyant</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Review of restricted experiment requests, division of select agents and toxins, centers for disease control and prevention, 2006-2013.</article-title><source><italic toggle="yes">Health Secur.</italic></source><volume>13</volume><fpage>307</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1089/hs.2015.0021</pub-id><pub-id pub-id-type="pmid">26347984</pub-id><pub-id pub-id-type="pmcid">PMC4582684</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solanki</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Varshney</surname><given-names>R.</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>P.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Non-infectious outer membrane vesicles derived from <italic toggle="yes">Brucella abortus</italic> S19&#916;<italic toggle="yes">per</italic> as an alternative acellular vaccine protects mice against virulent challenge.</article-title><source><italic toggle="yes">Int. Immunopharmacol.</italic></source><volume>90</volume>:<issue>107148</issue>. <pub-id pub-id-type="doi">10.1016/j.intimp.2020.107148</pub-id><pub-id pub-id-type="pmid">33189614</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soler-Llor&#233;ns</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gil-Ram&#237;rez</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zabalza-Barangu&#225;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Iriarte</surname><given-names>M.</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Z&#250;&#241;iga-Ripa</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Mutants in the lipopolysaccharide of <italic toggle="yes">Brucella ovis</italic> are attenuated and protect against <italic toggle="yes">B. ovis</italic> infection in mice.</article-title><source><italic toggle="yes">Vet. Res.</italic></source><volume>45</volume><fpage>1</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s13567-014-0072-0</pub-id><pub-id pub-id-type="pmid">25029920</pub-id><pub-id pub-id-type="pmcid">PMC4107470</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spink</surname><given-names>W. W.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>D.</given-names></name></person-group> (<year>1954</year>). <article-title>Experimental studies on the significance of endotoxin in the pathogenesis of brucellosis.</article-title><source><italic toggle="yes">J. Clin. Invest.</italic></source><volume>33</volume><fpage>540</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1172/JCI102924</pub-id><pub-id pub-id-type="pmid">13152193</pub-id><pub-id pub-id-type="pmcid">PMC1087268</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spink</surname><given-names>W. W.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Finstad</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mallet</surname><given-names>E.</given-names></name></person-group> (<year>1962</year>). <article-title>Immunization with viable <italic toggle="yes">Brucella</italic> organisms. Results of a safety test in humans.</article-title><source><italic toggle="yes">Bull. World Health Organ.</italic></source><volume>26</volume><fpage>409</fpage>&#8211;<lpage>19</lpage>.<pub-id pub-id-type="pmid">13915813</pub-id><pub-id pub-id-type="pmcid">PMC2555657</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stranahan</surname><given-names>L. W.</given-names></name><name name-style="western"><surname>Arenas-Gamboa</surname><given-names>A. M.</given-names></name></person-group> (<year>2021</year>). <article-title>When the going gets rough: the significance of <italic toggle="yes">Brucella</italic> lipopolysaccharide phenotype in host-pathogen interactions.</article-title><source><italic toggle="yes">Front. Microbiol.</italic></source><volume>12</volume>:<issue>713157</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.713157</pub-id><pub-id pub-id-type="pmid">34335551</pub-id><pub-id pub-id-type="pmcid">PMC8319746</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Frasch</surname><given-names>C. E.</given-names></name></person-group> (<year>1982</year>). <article-title>A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.</article-title><source><italic toggle="yes">Anal. Biochem.</italic></source><volume>119</volume><fpage>115</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0003-2697(82)90673-X</pub-id><pub-id pub-id-type="pmid">6176137</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uzureau</surname><given-names>S.</given-names></name><name name-style="western"><surname>Godefroid</surname><given-names>M.</given-names></name><name name-style="western"><surname>Deschamps</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lemaire</surname><given-names>J.</given-names></name><name name-style="western"><surname>De Bolle</surname><given-names>X.</given-names></name><name name-style="western"><surname>Letesson</surname><given-names>J. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Mutations of the quorum sensing-dependent regulator VjbR lead to drastic surface modifications in <italic toggle="yes">Brucella melitensis</italic>.</article-title><source><italic toggle="yes">J. Bacteriol.</italic></source><volume>189</volume><fpage>6035</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00265-07</pub-id><pub-id pub-id-type="pmid">17557825</pub-id><pub-id pub-id-type="pmcid">PMC1952030</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaara</surname><given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>Agents that increase the permeability of the outer membrane.</article-title><source><italic toggle="yes">Microbiol. Rev.</italic></source><volume>56</volume><fpage>395</fpage>&#8211;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkq040</pub-id><pub-id pub-id-type="pmid">1406489</pub-id><pub-id pub-id-type="pmcid">PMC372877</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valvano</surname><given-names>M. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Export of O-specific lipopolysaccharide.</article-title><source><italic toggle="yes">Front. Biosci.</italic></source><volume>8</volume>:<fpage>452</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.2741/1079</pub-id><pub-id pub-id-type="pmid">12700099</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Valvano</surname><given-names>M. A.</given-names></name></person-group> (<year>2015</year>). &#8220;<article-title>Chapter 4. Genetics and biosynthesis of lipopolysaccharide</article-title>,&#8221; in <source><italic toggle="yes">Molecular Medical Microbiology</italic></source>, <edition>2nd Edn</edition>. (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Ltd</publisher-name>), <fpage>55</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-397169-2.00004-4</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Vassen</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>). <source><italic toggle="yes">Polarity of Envelope Growth and Heterogeneity of the Outer Membrane of Brucella Abortus.</italic></source><comment>Ph. D. Thesis</comment>. <publisher-loc>Namur</publisher-loc>: <publisher-name>University of Namur</publisher-name>.</mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014a</year>). <article-title>Effects of partial deletion of the <italic toggle="yes">wzm</italic> and <italic toggle="yes">wzt</italic> genes on lipopolysaccharide synthesis and virulence of <italic toggle="yes">Brucella abortus</italic> S19.</article-title><source><italic toggle="yes">Mol. Med. Rep.</italic></source><volume>9</volume><fpage>2521</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2014.2104</pub-id><pub-id pub-id-type="pmid">24718931</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>G. M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lang</surname><given-names>X. L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y. L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X. Y.</given-names></name><etal/></person-group> (<year>2014b</year>). <article-title>Immunogenic response induced by <italic toggle="yes">wzm</italic> and <italic toggle="yes">wzt</italic> gene deletion mutants from <italic toggle="yes">Brucella abortus</italic> S19.</article-title><source><italic toggle="yes">Mol. Med. Rep.</italic></source><volume>9</volume><fpage>653</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2013.1810</pub-id><pub-id pub-id-type="pmid">24247358</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Niu</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X. L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>T. L.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Evaluation of a <italic toggle="yes">Brucella melitensis</italic> mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.</article-title><source><italic toggle="yes">Microbes Infect.</italic></source><volume>16</volume><fpage>633</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2014.06.013</pub-id><pub-id pub-id-type="pmid">25043564</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitfield</surname><given-names>C.</given-names></name></person-group> (<year>1995</year>). <article-title>Biosynthesis of lipopolysaccharide O antigens.</article-title><source><italic toggle="yes">Trends Microbiol.</italic></source><volume>3</volume><fpage>178</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/s0966-842x(00)88917-9</pub-id><pub-id pub-id-type="pmid">7542987</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Ovchinnikova</surname><given-names>O. G.</given-names></name><name name-style="western"><surname>Koizumi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mainprize</surname><given-names>I. L.</given-names></name><name name-style="western"><surname>Kimber</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Lowary</surname><given-names>T. L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Single polysaccharide assembly protein that integrates polymerization, termination, and chain-length quality control.</article-title><source><italic toggle="yes">Proc. Natl. Acad. Sci. U S A.</italic></source><volume>114</volume><fpage>E1215</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1613609114</pub-id><pub-id pub-id-type="pmid">28137848</pub-id><pub-id pub-id-type="pmcid">PMC5321029</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolter</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Lister</surname><given-names>P. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Mechanisms of &#946;-lactam resistance among <italic toggle="yes">Pseudomonas aeruginosa</italic>.</article-title><source><italic toggle="yes">Curr. Pharm. Des.</italic></source><volume>19</volume><fpage>209</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.2174/1381612811306020209</pub-id><pub-id pub-id-type="pmid">22894618</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wood</surname><given-names>P. J.</given-names></name></person-group> (<year>1980</year>). <article-title>Specificity in the interaction of direct dyes with polysaccharides.</article-title><source><italic toggle="yes">Carbohydr. Res.</italic></source><volume>85</volume><fpage>271</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/S0008-6215(00)84676-5</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Zabalza Barangu&#225;</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <source><italic toggle="yes">Desarrollo De Vacunas Marcadas con GFP Frente a la Brucelosis Ovina y Tests Diagn&#243;sticos Asociados.</italic></source><comment>Ph. D. Thesis</comment>. <publisher-loc>Navarre</publisher-loc>: <publisher-name>Public University of Navarre</publisher-name>.</mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Arce-Gorvel</surname><given-names>V.</given-names></name><name name-style="western"><surname>Conde-&#193;lvarez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Moriy&#243;n</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>J. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Vaccine development targeting lipopolysaccharide structure modification.</article-title><source><italic toggle="yes">Microbes Infect.</italic></source><volume>20</volume><fpage>455</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2017.11.006</pub-id><pub-id pub-id-type="pmid">29233768</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>